ETIOLOGICAL TREATMENT METHOD FOR TREATING CANCER AND VIRAL INFECTIONS USING FUNGICIDES

... 1- Initialement il y a mutation virale oncogénique de nature fongique intracellulaire entraînant la transformation pathologique de l'ADN cellulaire humain en ADN cellulaire fongique étranger: C'est la cause essentielle de la prolifération dite «anarchique» des cellules tumorales malignes (cellules fongiques indépendantes). 2- Cette présente invention consiste à démontrer que le virus et les cellule s cancéreuses ont une origine et/ou une nature fongique(s) et ils sont conséquemment détruits radicalement par les fongicides. 3- Cette méthode de thérapeutique antifongique spécifique et étiologique a pour but de détruire d'une façon totale, rationnelle et radicale toutes les cellules néoplasmiques accumulées dans les cancers, métastases et disséminées partout dans le corps humain, et tous les virus non-oncogènes mais paralysants et/ou lytiques dans les infections virales (y compris le SIDA). 4- Cette invention est basée initialement sur un concept totalement original de nature fongique du virus ...

Preparation method and application of biological agent with no drug resistance

Anti-hepatitis B virus and antitumor traditional Chinese medicine composition, preparation with same and application of anti-hepatitis B virus and antitumor traditional Chinese medicine composition

Medicine for treating hepatitis B and preparation method thereof

Traditional Chinese medicinal composition for treating liver tumor

PREPARATION MEDICAMENTEUSE DESTINEE A COMBATTRE L'ASSUETUDE AU TABAC

Elle comprend l'association en proportion déterminée de neuf substances végétales dont l'action est synergique. Elle doit être administrée exclusivement par voie orale et peut être préparée sous diverses présentations liquides et solides. Son utilisation permet de rendre désagréable l'arôme du tabac au point d'en entraîner l'arrêt immédiat; - de substituer un alcaloïde non toxique et dépourvu d'effet d'accoutumance à la nicotine; - de combattre la sensation de manque et les troubles de l'humeur observés fréquemment au début du sevrage ...

A MEDICATED PLASTER

NATURAL PRODUCT COMPOSITION FOR USE IN TREATING CANCER

Nouveau procédé et nouvelles compositions pharmaceutiques, destinés à être utilisés pour combattre le cancer. Ledit procédé consiste à ingérer et/ou à appliquer une composition préparée à l'aide d'extraits d'une ou plusieurs plantes choisies dans le groupe constitué de Centaurea, Capsicum, Sambucus, Lobelia, Cammiphora produisant la myrrhe, Echinacea, Hydrastis canadensis et myrte commun. Des extraits d'une ou plusieurs de ces plantes se sont révélés actifs contre des cancers résistant à des agents anticancéreux connus, et des mélanges de deux ou trois de ces plantes ainsi que des mélanges de toutes ces plantes se sont révélés avoir une activité contre le cancer.

Localized topical hyperbaric therapeutic instrument

A localized topical hyperbaric therapeutic instrument, comprising: a primary airbag, which is a chamber with an opening at an end; an oxygen generating device, which comprises an oxygen generator and a first pressure controller, wherein the oxygen generator has an oxygen outlet which communicates with the primary airbag through a first air inlet line and supplies oxygen into the primary airbag, and wherein the first pressure controller controls an amount of oxygen supplied to the primary airbag by the oxygen generator; a massage device; a heating piece, which is arranged in the primary airbag and generates heat; a treatment unit, which is arranged in the primary airbag in a detachable manner, disposed at a position corresponding to the heating piece, and comprises medical ingredients which are volatile upon heating.

HERBAL COMPOSITION FOR TREATMENT OF BACK PAIN

The present invention encompasses compositions and methods for reducing back pain in a subject.

Kidney-tonifying and clearing mixture and preparation method thereof

Eye-moistening and eyesight-improving pharmaceutical composition as well as preparation method and application thereof

Medicine for treating chronic obstructive pulmonary disease and cough, and preparation method thereof

Traditional Chinese medicine composition for preventing and treating oculopathy

Excessive tobacco consumption treatment compsn. - contains capsicum, aconite, ballota, crataegus, drosera, grindelia, lobelia, passion flower and white willow

Composition medicamenteuse destinee a etre administree sous forme d'aerosol

Composition medicamenteuse destinee a etre administree sous forme d'aerosol, caracterisee en ce qu'elle contient en poids des principes actifs : - de 50 a 99,995 % d'huiles essentielles vegetales, - de 0,005 a 40 % de substances bronchodilatatrices, la somme des constituants indiques devant, dans chaque cas, etre egale a 100 % en poids. Caracterisee egalement en ce qu'elle contient de l'ethyldiglycol a raison de 20 a 93 % du poids total de la composition et du monopropylene glycol a raison de 1 a 40 % du poids total de la composition. Application envisagee : traitement et prevention des pathologies respiratoires chez l'animal ou l'humain.

PREPARATION OF INSOLUBLE POLYSACCHARIDES OBTAINED FROM PLANT CELL CULTURES IN SUSPENSION FOR THE TREATMENT OF CLOSTRIDIUM DIFFICILE INFECTIONS

Suppositorium

ANTI-EOP READING TABLE DRUG

Shenlingbaizhu granules and preparation method thereof

Disclosed are shenlingbaizhu granules and a preparation method thereof, wherein the shenlingbaizhu granules comprise an extract of raw material medicines and excipients, the raw material medicines being: 400 parts by weight of ginseng, 400 parts by weight of tuckahoe, 400 parts by weight of rhizoma atractylodis macrocephalae stir-fried with bran, 400 parts by weight of yam, 300 parts by weight of fried white hyacinth bean, 200 parts by weight of lotus seed, 200 parts by weight of coix seed stir-fried with bran, 200 parts by weight of fructus amomi, 200 parts by weight of platycodon grandiflorum, and 400 parts by weight of licorice, wherein the excipients comprise citric acid, stevioside and lactose, and the granules are dispersed by adding an appropriate amount of water and then obtaining a clear solution.

A pharmaceutical composition for treating nephropathy and its preparation method thereof

Drug composition for treating black goat pox and preparation method thereof

Blood sugar reducing and body strengthening pill formula

Health-preserving tea for preserving and moisturizing viscera and skin and preparation method thereof

ГРАНУЛЫ ШЭНЬ ЛИН БАЙ ЧЖУ И СПОСОБ ИХ ПОЛУЧЕНИЯ

Группа изобретений относится к фармацевтической промышленности, а именно к гранулам для традиционной китайской медицины и к способу их получения. Способ получения гранулы для традиционной китайской медицины, причем сырьевые лекарственные вещества включают:400 мас. ч. Radix Ginseng, 400 мас. ч. Poria, 400 мас. ч. обжаренных с отрубями Rhizoma Atractyldis Macrocephalae, 400 мас. ч. Rhizoma Dioscoreae, 300 мас. ч. обжаренных Semen Dolichoris Album, 200 мас. ч. Semen Nelumbinis, 200 мас. ч. обжаренных с отрубями Semen Coicis, 200 мас. ч. Fructus Amomi Villosi, 200 мас. ч. Radix Platycodonis и 400 мас. ч. Radix Glycyrrhizae, где способ получения включает определенные стадии (варианты). Способ введения гранулы, полученной вышеописанными способами, включающий введение гранулы ребенку, страдающему от диареи, где ребенку 3-5 лет, введение осуществляют 3 раза в сутки по 1 г за один раз, и ребенку 5-14 лет введение осуществляют 3 раза в сутки по 2 г за один раз. Применение гранулы, полученной вышеописанными ...

LIQUID VAPE BASE AND EXTRACTION PROCESS

A botanical matrix and a base are disclosed for use in producing vapes. The base includes propanediol, vegetal glycerin and a blend of two or more botanical additives. The propanediol and glycerin may be lab produced for improved consistency. Additional ingredients including active ingredients may be added to the base to produce a vape. The botanical additives provide a base that has a smoother impression and reduces or eliminates throat burn.

ETIOLOGICAL TREATMENT METHOD FOR TREATING CANCER AND VIRAL INFECTIONS USING FONGICIDES

Jusqu'à ce jour tout le corps médical offciel mondial sait bien que la cause du cancer restait inconnue. Dans son Brevet Américain No 5,665,751 du 9 Sept. 1997 M.Camden a confirmé:"La cause exacte du cancer est inconnue". On a cherché à traiter le cancer par plusieurs moyens: Les produits chimiques anticancéreux très forts appelé chimiothérapie. Mais malheureusement cette thérapie est trop toxique pour le corps humain d'une part, d'autre les cellules cancéreuses deviennent très viterésistantes à cette chimiothérapie. Ainsi pour réduire ou inhiber la résistance des cellules cancéreuses et des microbes à l'égard de cette chimiothérapie et des antibiotiques, pour augmenter l'effet cytotoxique de cette chimiothérapie anticancéreuse et pour activer des macrophages, on a inventé des catalyseurs comme le "glucan phosphorulé solubre" (Brevet US No 4,761,402 de M. Williams et al) et le bloc copolymère polyéther (Brevet US No 5,817,321 de Alakhov, Valery Yu et al.). Pour inhiber la croissance des ...

Tea medicine for treating eczema

Capsule drug with functions of regulating menstruation and nourishing skin and preparation method

Diabetes treatment traditional Chinese medicine composition and preparation method and application thereof

Drug for treating cerebral infarction

Externally applied medicine for treating skin fungal infection

Preparation method and quality control method of Yulan Jiangtang capsule extract

Means of withdrawal from smoking

Cholera and Diarrhoea Cure.

... 11,980. Pearson, F. W. May 21. Medicines for internal use.-A preparation for the treatment of cholera and diarrhoea . consists of an extract in spirits of wine of American valerian, lobelia, skunk cabbage, scull-cap and cayenne.

Traditional Chinese medicine composition for treating rheumatic arthritis and preparation method of traditional Chinese medicine composition for treating rheumatic arthritis

Medicinal liquor composition for treating breast diseases and preparation method thereof

Excessive tobacco consumption treatment compsn. - contains capsicum, aconite, ballota, crataegus, drosera, grindelia, lobelia, passion flower and white willow

METHOD FOR PREPARING PHARMACEUTICAL COMPOSITION CONTAINING BALLOON FLOWER SAPONIN CONCENTRATE EXTRACTED FROM BALLOON FLOWER

The present invention relates to a pharmaceutical composition containing a large amount of platycodin D extracted from a balloon flower, which generates a pharmaceutical composition containing a large amount of platycodin D extracted from a skin layer of balloon flower roots to prepare a medicine having excellent effects for anti-inflammatory, anticancer, and pain relief, and to a method for preparing the same. According to the present invention, an extract containing a large amount of balloon flower saponin is extracted from balloon flower roots in a large amount, and an ultrafiltration membrane is used from the extract, and thus, particularly, balloon flower saponin containing a large amount of platycodin D can be concentrated to be produced. COPYRIGHT KIPO 2018 (AA) Start (BB) End (S102) Prepare balloon flower powder (S104) Input any one of water, an organic solvent, and a mixture (S106) Cool an extract (S108) Remove an insoluble material using a micro-filter (S110) Remove low molecule ...

The processing platycodon extract for increasing pharmaceutical ingredient of platycodon, method for manufacturing thereof

MIXED POWDER OF PLATYCODON GRANDIFLORUM WITH MOMORDIACA CHARANTIA, CAPSULES THEREOF AND METHOD FOR PREPARING SAME

The present invention relates to mixed powder of Platycodon grandiflorum with Momordiaca charantia, capsules thereof and a method for preparing the same. Particularly, dry powder of Platycodon grandiflorum including leaves, stems and roots thereof is mixed with that of Momordiaca charantia to provide mixed powder for preventing and treating various respiratory organ diseases and adult diseases caused by blood circulation disorder. The method for preparing mixed powder of Platycodon grandiflorum with Momordiaca charantia comprises the steps of: (S10) harvesting annual to perennial Platycodon grandiflorum including leaves, stems and roots and Momordiaca charantia, followed by washing; (S20) cutting each of the harvested Platycodon grandiflorum and Momordiaca charantia into a predetermined length; (S30) drying Platycodon grandiflorum and Momordiaca charantia with hot air in a dryer at a temperature higher than the boiling point of hydrocyanic acid gas; (S40) pulverizing each of the dried Platycodon ...

THERAPEUTIC AND PHARMACEUTICAL COMPOSITION OR FOOD COMPOSITION HAVING ANTIALLERGIC FUNCTION, CONTAINING BALLOON FLOWER ROOT EXTRACT BIOCONVERTED VIA FERMENTATION BY MICROBE (MYCELIUM OF BASIDIOMYCETES) OR ADDITIONAL ENZYME TREATMENT

The present invention relates to a therapeutic and pharmaceutical composition or food composition having an antiallergic function, containing a balloon flower root extract which is bioconverted via fermentation by microbe (mycelium of basidiomycetes) and enzyme treatment. The balloon flower root extract which is bioconverted via fermentation by mycelium of basidiomycetes and enzyme treatment contains a larger amount of antiallergic substances than unfermented balloon flower root, thereby exhibiting effects of reducing allergic reactions when processed into food products by using the extract. COPYRIGHT KIPO 2016 (AA) Production process chart (BB) Balloon flower root (CC) Washing, drying, crushing (DD) Culture(Fermentation) medium process(Enzymatic treatment/ heat treatment sterilization process) (EE) LE Basidiomycota hyphae inoculation (FF) Biological conversion(LE Basidiomycota hyphae) fermentation process (GG) Biological conversion enzymatic treatment process (HH) Heat treatment/ sterilization ...

MANUFACTURING METHOD OF HIGH QUALITY RED BELLFLOWER ROOT AND RED BELLFLOWER ROOT MANUFACTURED BY SAME

The present invention relates to a manufacturing method of high quality red bellflower roots which comprises a first steaming step of steaming bellflower roots at 60 to 120°C for 2 to 24 hours in the relative humidity of 90 to 110%, and a first drying step of inserting the firstly steamed bellflower roots into a dryer, and drying the bellflower roots at 30 to 100°C for 6 to 72 hours; and to red bellflower roots manufactured by the method. According to the present invention, red bellflower roots with improved flavor and functionality and the increased contents of crude saponin can be produced. COPYRIGHT KIPO 2017 (AA) Raw balloon flower (BB) First red bellflower roots (CC) Second red bellflower roots (DD) Third red bellflower roots (EE) Fourth red bellflower roots ...

AN ANTINEOPLASTIC DRUG

The present invention disclosed a novel Antineoplastic drug which is mainly composed of the following Chinese medicinal herbs: Panax ginsing, Poria cocos, Atractylodes macrocephala, Angelic sinensis, Astragalus membranaceus, Curcuma zedoaria, Scutellaria baicalensis, Coptis chinensis, Glycyrrhiza uralensis, Crataegus pinatifida, Hordeum vulgare, Schisandra chinensis, Hedyotis diffusa, Ophiophogon japonicus, and Lobelia chinesis lour. It has been used clinically for 20 years, including 15 years in China and 5 years in Israel. Thousands of tumor patients have taken the antineoplastic drug with 69.7 % of effective rate and 84.3 % in association with radiotherapy and chemotherapy. Clinical and experimental evidence show that it can improve the immunity of organism, inhibit and reverse tumor cells; repose, improve the circulation of blood to inhibit the growth and metastasis of tumor; increase the sensitivity to radiotherapy and chemotherapy and alleviate the toxic and side effect which resulted ...

COMPOSITION CONTAINING AN EXTRACT OBTAINED BY A WATER-CONTAINING ORGANIC SOLVENT, AND A PROCESS FOR PREPARING THE SAME

A composition containing an extract obtained by a water-containing organic solvent, comprising: (a) an extract containing active ingredients almost insoluble in water, said extract being obtained from plant tissues by extraction with a water-containing organic solvent, and at least one of (b) a water-soluble high-molecular substance and (c) a fatty acid ester or polyglycerol. This composition can be formulated into preparations not containing ethanol, i.e. solid preparations including tablets, granules, and powder preparations, or nonalcoholic liquid preparations such as drinkable preparations and syrups, in such a way that the extract contained is well absorbed through the digestive tract.

Granule prescription for treating yin-deficiency type restlessness during pregnancy

Drug composition for treating swine influenza and preparation method and application thereof

COMPOSITION FOR ENHANCING IMMUNITY, PHARMACEUTICAL AND FUNCTIONAL FOOD HAVING THE COMPOSITION

Verfahren zur Gewinnung der in Wasser unloeslichen Inhaltsstoffe des Crataegus

Wound plaster and preparation method and application thereof

Traditional Chinese medicinal composition used for treating chronic cholecystitis

New formula of traditional Chinese medicine for treating acne vulgaris

Traditional Chinese medicine composition Xiaoening

COMPOSITION FOR PRODUCING DEGLU-PLATYCODIN D AND METHOD FOR PRODUCING DEGLU PLATYCODIN D AND USE OF DEGLU PLATYCODIN D

Composition of a liquid dietary supplement to treat symptoms of autism spectrum disorders in children

The object of the present invention is to provide an all-natural dietary supplement formulation that may be beneficial to the management of behavioral and neurological symptoms associated with autism spectrum disorders; symptoms that may not be effectively improved by conventional drug treatment and behavioral therapy alone.

Complex prescription of chinese medicine for the treatment of extensive cancer

A complex prescription of Chinese medicine for the treatment of extensive cancer, or cancer of relation type of the lymph node. The ingredients of this complex prescription are Pilose asiabell root, Astragalus root, Coix seed, Eupatorium, Tangerine peel, Justicia, Prunella spike, Serissa serissoides, Capejasmine fruit, Forsythia fruit, Red peony root, Rhubarb, Blister beetle, Oldenlandia, Polygonum perfoliatum, Subprostrate sophora root, Shrubalthea bark, Rhizome of arisaema, Chinese Lobelia, Ampelopsis, Globethistle, Pyrrosia leaf, Frankincense, Myrrh, Paris chinensis franch, Patrinia, Dahurian angelica root, Belamcanda rhizome, Dandelion herb, Lemmaphyllum microphyllum, Gleditsia spine, Pubescent angelica root, Chinese Ephedra, and Cimicifuga rhizome. The extraction is improved and it also adopts Indian Bread (Poria), an effective cancer medicine, as excipient.

GINKO, OR OTHER MEDICINAL PLANT EXTRACTS WITH ADDITIVE FOR IMPROVED ASSIMILATION

Liquid vape base and extraction process

A botanical matrix and a base are disclosed for use in producing vapes. The base includes propanediol, vegetal glycerin and a blend of two or more botanical additives. The propanediol and glycerin may be lab produced for improved consistency. Additional ingredients including active ingredients may be added to the base to produce a vape. The botanical additives provide a base that has a smoother impression and reduces or eliminates throat burn.

Selenium-rich herba dentrobii officinale kimura ex migo chewable tablet

Prostatic cancer rehabilitation liquid and preparation method thereof

Gel prepared from biomass pyrolysis fluid and application thereof to preparation of gynecological external use medicine

Traditional Chinese medicine composition for promoting wound healing and preparing method thereof

Medicinal composition intended for administration in aerosol form

FUNCTIONAL APHRODISIAC ROLLED HERBAL BIDIS AND CIGARETTES

The present invention relates to an herbal formulation comprising the synergistic combination of fiber/powder/granules of the aerial parts of at least two plants selected from the group comprising Marticaria chamomilla, Hygrophila auriculata, Aquilaria agallocha, Valeriana wallichii, Nordostachys jatamansi, Artemisia pallen, Papaver somniferum(mainlyleaf), Evolvulus alsinoides, Ficus benghalensis, Echinops echinatus, Lobelia nicotianaefolia, Mucuna pruriens, Tribulus terrestris and along with one or more flavoring agents selected from essential/aromatic oils. Said composition is aromatic and having pleasant smell, are non-irritants, no itching, and has no toxic- effects, no breathing problems, has no bronchial irritation, no pain in nose, ear and throat, has no headache, not allergic. There are no health hazards or health risk in normal subjects when the person attempts to reduce their use of nicotine or non nicotine bidis and cigarettes or stop using such products altogether. At the same ...

Compositions and methods for an orally administered inhibitor of biting insects

The present disclosure concerns methods and compositions to inhibit insects from biting a subject. In preferred embodiments, the compositions may be administered orally, for example using a spray bottle to deliver to the mouth. In certain embodiments, the compositions and methods are effective to reduce swelling, itching, redness and/or inflammation of the local area of an insect bite. The compositions may include one or more herbs selected from the group consisting of rice bran, peppermint, barley grass, lobelia; chlorella, watercress, alfalfa and parsley and one or more vitamins selected from the group consisting of thiamin (B-1), riboflavin (B-2), niacin (B-3), pantothenic acid (B-5), pyridoxine (B-6), folic acid (B-9), cyanocobalamin (B-12), choline, inositol, d-biotin, para-aminobenzoic acid, and lecithin. Administration of effective amounts of the compositions is sufficient to inhibit insects from biting and/or treat insect affected areas of a subject.

Health-care traditional Chinese medicine with effects of clearing away heat and toxic materials

Traditional Chinese medicine capable of eliminating breast masses and preparation method thereof

Organism immune protection and virus control agent and preparation method thereof

The invention relates to an organism immune protection and virus control agent and a preparation method thereof, belongs to the technical field of virus control, and solves the problem of providing the virus control agent which can improve the body immune protection capability and has excellent sterilization and disinfection performance. The control agent consists of the following main medicines,an auxiliary medicine and an adjuvant in parts by mass: the main medicines are composed of 10-50 parts of radix tetrastigme extract, 10-40 parts of anoectochilus roxburghii extract and 10-40 parts ofradix adenophorae extract; the auxiliary medicine is composed of 12-96 parts of a composite Chinese herbal medicine extract; and the adjuvant is composed of 1.02-35 parts of an adjuvant agent, and theadjuvant agent is at least one of benzalkonium chloride, tinidazole, glycerin, citric acid, sea buckthron oil, peppermint essential oil and active water. The control agent is excellent in preventionand treatment ...

PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING DIABETES CONTAINING EXTRACT OF AERIAL PARTS OF BALLOON FLOWER

The present invention relates to a pharmaceutical composition for preventing or treating diabetes containing an extract of aerial parts of balloon flower or a fraction thereof, a method for preventing or treating diabetes including a step for injecting the pharmaceutical composition into an individual except human, and a food composition for improving diabetes containing the extract of aerial parts of balloon flower or the fraction thereof. The composition containing the extract of aerial parts of balloon flower or the fraction thereof can relieve or treat symptoms of diabetes without side effects, thereby being applicable to development of various types to preparations for treating diabetes. COPYRIGHT KIPO 2017 (AA) Changes in pancreatic islet size (μm^2) (B1,B2) Normal bacteria (C1,C2) Untreated control group (DD) Roots (EE) Aerial part (FF) Extract group (1 μg/mL) (GG) Bellflower root extract-treated group (HH) Bellflower aerial part extract-treated group ...

PHARMACEUTICAL COMPOSITION AND HEALTH-AID FOOD COMPRISING ORGANIC SOLVENT FRACTIONS OF PLATYCODON GRANDIFLORUM OR RED PLATYCODON GRANDIFLORUM AS ACTIVE INGREDIENT FOR PREVENTING OR TREATING THROMBOSIS

The present invention relates to a pharmaceutical composition and health-aid food comprising organic solvent fractions of the underground parts of Platycodon grandiflorum or red Platycodon grandiflorum as an active ingredient for preventing or treating thrombosis. More particularly, the present invention relates to a pharmaceutical composition and health-aid food comprising organic solvent fractions of Platycodon grandiflorum or red Platycodon grandiflorum, obtained by forming an ethanol extract of Platycodon grandiflorum or red Platycodon grandiflorum prepared by repeatedly digesting and drying Platycodon grandiflorum, and carrying out sequential fractionation thereof with an organic solvent, as an active ingredient for preventing or treating/improving thrombosis. The organic solvent fractions of the underground parts of Platycodon grandiflorum or red Platycodon grandiflorum as an active ingredient for preventing or treating thrombosis shows strong anti-thrombotic activity derived from ...

MEANS OF WITHDRAWAL FROM SMOKING

Mischung getrockneter Pflanzenteile zur Herstellung eines Aufgussgetränks und Verwendung des Aufgussgetränks zur Pflege und/oder Aufzucht von Hunden

Verwendung eines Aufgussgetränks, welches mittels heißem Wasser aus einer Mischung getrockneter Pflanzenteile gewonnenen ist, zur Aufzucht und/oder Pflege von Hunden.

Herbal composition for the treatment of drug addiction

Preparation method of compound lobelia liposome and dropping pills thereof

Composition for preventing and treating cancer cells and cardiovascular disease, and preparation method thereof

Prostatic cancer treatment liquid and preparing method thereof

Traditional Chinese medicine composition used for treating urinary tract infection

formulation for the treatment of symptoms associated with smoking cessation or psychotropic weaning

Method of preparation of drugs

Use of diosmetin and its derivatives for cosmetic or therapeutic pigmentation of skin and hair, e.g. for treating vitiligo, acts by stimulating melanogenesis

L'invention concerne l'utilisation de la diosmétine, d'un de ses glycosides, d'un de ses sulfates ou d'un extrait de plante contenant l'un d'eux ou de leurs mélanges à titre d'agent pigmentant de la peau et/ou des poils et/ou des cheveux, l'extrait de plante ne provenant pas du genre Chrysanthemum. L'invention concerne également la méthode de traitement cosmétique par voie orale ou topique associée.

ORIENTAL MEDICAL HERB COMPOSITION FOR PREVENTING AND ALLEVIATING RESPIRATORY DISEASES

The present invention relates to a novel oriental medical herb composition to prevent and alleviate respiratory diseases comprising cough, asthma, bronchitis, allergic coryza, lung cancer, etc. The novel oriental medical herb composition comprises a mixed extract of balloon flower roots and Chaga mushroom as an active ingredient and adds one or more extracts selected from Codonopsis lanceolata, pears, mint, jujube, ginger, Cheongyang red pepper and dried Chinese quince which are other oriental medicinal components, thereby preventing and alleviating respiratory diseases such as cough, asthma, bronchitis, allergic coryza, lung cancer, etc. COPYRIGHT KIPO 2017 (AA) 5-Lipoxygenase Inhibition rate (%) (BB) Drawing 1 (CC) Example (DD) Comparative example (EE) Sample concentration (ppm) (FF) Figure 1. 5-Lypoxygenase inhibition rate (%) (GG) Concentration (PPM) (HH) Example (II) Comparative example ...

Vaporized Medicants and Methods of Use

A method and formulation for delivering an active analgesic compound, such as an opiate, in a vaporized state using low temperatures to vaporize the formulation. The formulation contains an inert non-reactive compound that lowers the heat of vaporization of the formulation, and the active compound. The formulation may optionally contain glycerin, alcohol, and/or water. Examples of inert non-reactive compounds that can sufficiently lower the heat of vaporization of the formulation include propylene glycol, vegetable glycerin and polysorbate. The formulation can be vaporized using a hand-held low temperature vaporizer or atomizer.

Shenlingbaizhu granules and preparation method thereof

Disclosed are shenlingbaizhu granules and a preparation method thereof, wherein the shenlingbaizhu granules comprise an extract of raw material medicines and excipients, the raw material medicines being: 400 parts by weight of ginseng, 400 parts by weight of tuckahoe, 400 parts by weight of rhizoma atractylodis macrocephalae stir-fried with bran, 400 parts by weight of yam, 300 parts by weight of fried white hyacinth bean, 200 parts by weight of lotus seed, 200 parts by weight of coix seed stir-fried with bran, 200 parts by weight of fructus amomi, 200 parts by weight of platycodon grandiflorum, and 400 parts by weight of licorice, wherein the excipients comprise citric acid, stevioside and lactose, and the granules are dispersed by adding an appropriate amount of water and then obtaining a clear solution.

Plant antipruritic antibacterial liquid and preparation method and application thereof

MANUFACTURING METHOD FOR PLATYCODON SAPONIN COMPOSITION

MASK HAVING FACIAL PACK FUNCTION

The present invention relates to a mask having a facial pack function, and more specifically, comprises: a mask main body (100) for covering a nose and a mouth; and a pair of wearing bands (200) which are symmetrically connected to both end portions of the mask main body (100). The mask main body (100) comprises a sheath (101), an inner sheath (102), and a filter unit (300) which is inserted into a place corresponding to the nose and the mouth between the sheath (101) and the inner sheath (102). An ample unit (400) is inserted into an entire or a part of an area where the filter unit (300) between the sheath (101) and the inner sheath (102) is not inserted. The ample unit (400) is provided by filling a composition (430) for a facial pack into an ample sheath (440) formed by a synthetic resin film. According to the present invention, a user using the mask can effectively protect a respiratory organ and a skin from fine dust. COPYRIGHT KIPO 2018 ...

PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING RESPIRATORY DISEASE CONTAINING MIXED MEDICINAL HERB EXTRACT

The present invention relates to a pharmaceutical composition for preventing or treating respiratory disease containing a mixed medicinal herb extract. More specifically, the present invention relates to a pharmaceutical composition which contains a mixed extract of citron, ginseng, balloon flower roots, and pear as an active ingredient, and also effectively suppresses respiratory inflammation and fibrosis. According to the present invention, the pharmaceutical composition for preventing and treating respiratory disease containing the mixed extract as the active ingredient can be useful for developing food compositions or pharmaceutical compositions for preventing, treating, or alleviating respiratory disease owing to excellent effects of suppressing respiratory inflammation and fibrosis in tissues. COPYRIGHT KIPO 2017 ...

Compound traditional Chinese medicine oral solution for treating acute pharyngitis

Traditional Chinese medicine preparation for treating spleen deficiency and stomach deficiency type persistent diarrhea in children

Recovery cream capable of avoiding scars and used for burns and scalds

External use type medicated wine for treating traumatic injuries and rheumatism

Mass-resolving pills for treating tumor and preparation method thereof

Drug for treating diabetes combined with traditional Chinese medicine and western medicine

Preparation method and applications of traditional Chinese medicine used for preventing breast tumor

Traditional Chinese medicine preparation for treating tumor and preparation method thereof

Use of an extract of the root of balloon-flower for preventing and treating a degenerative brain disease or for enhancing memory

Disclosed in this invention is a use of an extract of the root of balloon-flower for preventing and treating a degenerative brain disease or for enhancing memory.

GINKO, OR OTHER MEDICINAL PLANT EXTRACTS WITH ADDITIVE FOR IMPROVED ASSIMILATION

Preparation method of Baoyuanqiangshen wine

Anti-dermatitis body wash

PHARMACEUTICAL COMPOSITION

A method of treating a respiratory disease in an animal comprising the steps of administering to the animal an effective amount of a pharmaceutical composition comprising 1.5 parts by weight powdered fennel, 2.0 parts by weight powdered rhubarb, 1.0 part by weight powdered glycyrrhiza, 2.0 parts by weight powdered phellodendron bark, 1.0 part by weight powdered zedoary, 1.5 parts by weight powdered picrasma wood, 1.0 part by weight powdered matricaria chamomilla, 1.5 parts by weight powdered geranium herb, 1.0 part by weight powdered ginseng, 1.5 parts by weight powdered citrus unshiu peel, 1.0 part by weight powdered scutellaria root, 1.0 part by weight powdered magnolia bark, 2.0 parts by weight powdered oyster shell, 1.0 part by weight powdered cyperus rhizome, 2.0 parts by weight powdered platycodon root, 2.0 parts by weight powdered melia azedarach, 1.0 part by weight powdered cnidium rhizome, 2.0 parts by weight sodium bicarbonate and 4.0 parts by weight precipitated calcium carbonate in 30 parts by weight of the composition. 1. A method of treating a respiratory disease in an animal comprising the steps of administering to the animal an effective amount of a pharmaceutical composition comprising:1.5 parts by weight powdered fennel;2.0 parts by weight powdered rhubarb;1.0 part by weight powdered glycyrrhiza;2.0 parts by weight powdered phellodendron bark;1.0 part by weight powdered zedoary;1.5 parts by weight powdered picrasma wood;1.0 part by weight powdered matricaria chamomilla;1.5 parts by weight powdered geranium herb;1.0 part by weight powdered ginseng;1.5 parts by weight powdered citrus unshiu peel;1.0 part by weight powdered scutellaria root;1.0 part by weight powdered magnolia bark;2.0 parts by weight powdered oyster shell;1.0 part by weight powdered cyperus rhizome;2.0 parts by weight powdered platycodon root;2.0 parts by weight powdered melia azedarach;1.0 part by weight powdered enidium rhizome;2.0 parts by weight sodium bicarbonate; and4.0 parts ...

Herbal composition for treating cancer

An herbal composition and a method for treating cancer, especially for lung cancer, useful for enhancing the quality of life.

Use of a Traditional Chinese Medicine Composition for Manufacturing a Health Food or Medicament for Preventing and Alleviating Physical Fatigue

The present invention provides a use of traditional Chinese medicine composition for manufacturing a health food or medicament for preventing and alleviating physical fatigue. The composition consists of 5-90 parts by weight of Radix Panacis Quinquefolii, 5-160 parts by weight of 1-90 parts by weight of fermented powder and/or 1-120 parts by weight of , and these ingredients are made from Chinese crude drugs or from Chinese crude drug extracts in amounts equivalent to those of the Chinese crude drugs. The composition may further contain 5-90 parts by weight of Flos Rosae Rugosae. The present invention also relates to the use of said composition in the manufacture of prophylactic or therapeutic health foods or medicaments for reducing blood lipids, for resisting oxidation, and for enhancing anoxia endurance. The medicine composition of the present invention can be prepared into any conventional dosage forms by adding any pharmaceutically acceptable auxiliary agents. 1GanodermaCordyceps sinensis. A method of resisting oxidation or enhancing anoxia endurance comprising the step of administering a composition to a subject , wherein the composition comprises raw materials of 10-50 parts by weight of Radix Panacis Quinquefolii , 10-50 parts by weight of , and 10-50 parts by weight of fermented powder , or water extracts of said raw materials , as active ingredients.2. The method of claim 1 , characterized in that said raw materials further include 10-40 parts by weight of Flos Rosae Rugosae claim 1 , or a water extract of 10-40 parts by weight of Flos Rosae Rugosae.3GanodermaCordyceps sinensis. The method of claim 1 , characterized in that the raw materials are 30 parts of Radix Panacis Quinquefolii claim 1 , 40 parts of claim 1 , and 20 parts of fermented powder.4. The method of claim 3 , characterized in that said raw materials further include 30 parts by weight of Flos Rosae Rugosae claim 3 , or a water extract of 30 parts by weight of Flos Rosae Rugosae. ...

Pharmaceutical Composition and Methods for Modulating Immune System, Preventing, Pretreating and/or Treating Cancers

This invention provides a pharmaceutical composition for modulating immune system comprising at least one polysaccharide extracted from Radix Astragali, Radix Codonopsis, , or mixtures thereof, and their extraction process. The present invention further relates to a method of modulating immune system by applying said pharmaceutical composition to a subject suffering from cancers, and a method of preventing and/or pretreating and/or treating cancers in the subject, where said method comprises applying said pharmaceutical composition before/during chemotherapy. 1Ganoderma sinense. A pharmaceutical composition for modulating immune system comprising at least one polysaccharide extracted from Radix Astragali , Radix Codonopsis , , or mixtures thereof.2. The pharmaceutical composition according to claim 1 , wherein the at least one polysaccharide has a molecular weight in the range of 500-2 claim 1 ,500 kDa claim 1 , 600-2 claim 1 ,000 kDa claim 1 , or 700-1 claim 1 ,900 kDa.3. The pharmaceutical composition according to claim 1 , wherein the at least one polysaccharide comprises one or more constituents selected from the group of glucose claim 1 , galactose claim 1 , mannose claim 1 , rhamnose claim 1 , arabinose claim 1 , their dextrorotary and levorotary compounds claim 1 , and combinations thereof.4. The pharmaceutical composition according to claim 3 , wherein any two of the constituents of the at least one polysaccharide is in the molar ratio ranging from 1:30 to 30:1 claim 3 , 1:20 to 20:1 claim 3 , or 1:10 to 10:1.5. The pharmaceutical composition according to claim 3 , wherein the at least one polysaccharide comprises glucose claim 3 , galactose and mannose as the constituents in the molar ratio of 4.7:27.1:1.0.6. The pharmaceutical composition according to claim 3 , wherein the at least one polysaccharide comprises rhamnose claim 3 , arabinose claim 3 , glucose claim 3 , galactose and galacturonic acid as the constituents in the molar ratio of 0.03:1.00:0.27:0. ...

COMPOSITION FOR PREVENTING OR TREATING METABOLIC BONE DISEASES OR MENOPAUSAL SYMPTOMS

The present invention relates to a composition for preventing or alleviating metabolic bone diseases or menopausal symptoms, comprising a complex extract of and as an active ingredient. When the present invention is used, metabolic bone disease or menopausal symptoms can be effectively prevented or alleviated without side effects. 1. A pharmaceutical composition for preventing or treating a metabolic bone disease or a menopausal symptom , the composition comprising:{'i': Pueraria lobata', 'Platycodon grandiflorum, '(a) a complex extract of and as an active ingredient; and'}(b) a pharmaceutically acceptable carrier thereof.2Pueraria lobataPlatycodon grandiflorum. The composition of claim 1 , wherein a weight ratio (w/w) of to in the complex extract is 1:20 to 20:1.3. The composition of claim 1 , wherein the extract is a polar organic solvent extract.4. The composition of claim 3 , wherein the polar organic solvent is water claim 3 , an anhydrous or hydrated lower alcohol of 1-4 carbon atoms claim 3 , acetic acid claim 3 , or a mixture thereof.5Pueraria lobataPlatycodon grandiflorum. A food composition for preventing or alleviating a metabolic bone disease or a menopausal symptom claim 3 , the composition comprising a complex extract of and as an active ingredient.6Pueraria lobataPlatycodon grandiflorum. The food composition of claim 5 , wherein a weight ratio (w/w) of to in the complex extract is 1:20 to 20:1.7. The food composition of claim 5 , wherein the extract is a polar organic solvent extract.8. The food composition of claim 7 , wherein the polar organic solvent is water claim 7 , an anhydrous or hydrated lower alcohol of 1-4 carbon atoms claim 7 , acetic acid claim 7 , or a mixture thereof.9. A method for preventing claim 7 , alleviating claim 7 , or treating metabolic bone diseases or menopausal symptoms claim 7 , the method comprising:{'i': Pueraria lobata', 'Platycodon grandiflorum., 'administering to a subject in need thereof, a pharmaceutical composition ...

Kind of Chinese medicine and microcapsule preparation method suitable for nasopharyngeal carcinoma tumor inhibitor

The invention relates to the technical field of traditional Chinese medicine, and discloses a method of traditional Chinese medicine and microcapsule preparation suitable for nasopharyngeal cancer tumor inhibitors. A traditional Chinese medicine suitable for nasopharyngeal cancer tumor inhibitors, including: Hedyotis Diffusa, Scutellaria Barbata, Arrowshaped Tinospora Root, Rehmanniae Radix Preparata, Radix Curcumae, Crotonis Fructus, Leonurus Artemisia, Ramulus Cinnamomi, Forsythiae Fructus, Taraxacum, Radix Platycodonis and White Vinegar. Among them, the raw materials for the weight ratio are as follows: 60 grams of Hedyotis Diffusa, 30 grams of Scutellaria Barbata, 9-12 grams of Arrowshaped Tinospora Root, 18 grams of Rehmanniae Radix Preparata, 19 grams of Radix Curcumae, 7.5 grams of Crotonis Fructus, 10 grams of Leonurus Artemisia, 7-10 grams of Ramulus Cinnamomi, 10 grams of Forsythiae Fructus, 15-30 grams of Taraxacum, 10 g of Radix Platycodonis, and 30 ml of White Vinegar. 1. A Chinese medicine suitable for nasopharyngeal cancer tumor inhibitors , which is characterized in that it comprises: Hedyotis Diffusa , Scutellaria Barbata , Arrowshaped Tinospora Root , Rehmanniae Radix Preparata , Radix Curcumae , Crotonis Fructus , Leonurus Artemisia , Ramulus Cinnamomi , Forsythiae Fructus , Taraxacum , Radix Platycodonis and White Vinegaris and White Vinegar. Among them , the raw materials for the weight ratio are as follows: 60 grams of Hedyotis Diffusa , 30 grams of Scutellaria Barbata , 9-12 grams of Arrowshaped Tinospora Root , 18 grams of Rehmanniae Radix Preparata , 19 grams of Radix Curcumae , 7.5 grams of Crotonis Fructus , 10 grams of Leonurus Artemisia , 7-10 grams of Ramulus Cinnamomi , 10 grams of Forsythiae Fructus , 15-30 grams of Taraxacum , 10 g of Radix Platycodonis , and 30 ml of White Vinegar.2. A preparation method of traditional Chinese medicine microcapsules suitable for nasopharyngeal cancer tumor inhibitors is characterized in that it ...

MALE AND FEMALE INFERTILITY HERBAL COMPOSITION

An herbal composition that enhances and promotes fertility in both males and females by nourishing the kidney, regulating the liver and spleen, improving circulation of Qi and blood, and balancing the Yin and Yang through a unique composition consisting of natural herbs known in traditional Chinese medicine. The herbs create a synergy between each other that works to enhance fertility for both males and females. The composition consists of the following herbal ingredients mixed in varying weight percentages. goji berry, dodder seed, red sage root, green orange peel, processed fleece flower root, horny goat weed, codonopsis, raspberry, astragalus root, Chinese yam, white peony root, false daisy, mulberry, curcuma tuber, and cynomorium. The herbal ingredients are cleaned, purified and/or processed prior to formulation. The formulation process is at least partially dependent on the desired means of preparation and administering the composition. 1. An herbal composition for enhancing fertility in males and females , the composition comprising:about 3 to 15 weight percent Fructus Lycii, about 3 to 15 weight percent Semen Cuscutae, about 3 to 10 weight percent Radix Salviae Miltiorrhizae, about 1 to 5 weight percent Pericarpium Citri Reticulatae Viride preparata, about 3 to 15 weight percent Radix Polygoni Multiflori preparata, about 3 to 10 weight percent Herba Epimedii, about 3 to 15 weight percent Radix Codonopsis, about 3 to 15 weight percent Fructus Rubi, about 3 to 10 weight percent Radix Astragali, about 3 to 10 weight percent Rhizoma Dioscoreae, about 3 to 10 weight percent Radix Paeoniae Alba, about 3 to 10 weight percent Herba Ecliptae, about 5 to 10 weight percent Fructus Mori, about 3 to 10 weight percent Radix Curcumae, and about 3 to 10 weight percent Herba Cynomorii.2. The composition of claim 1 , wherein the composition is administered in at least one of the following ways: oral claim 1 , topical claim 1 , suppository claim 1 , intravenous claim 1 , ...

PHARMACEUTICAL COMPOSITIONS AND USE THEREOF

The present application relates to methods of preventing, treating or managing a respiratory disease and/or a viral infection (e.g., an influenza virus infection and COVID-19) using a pharmaceutical composition produced from one or more preparations of plant parts. Provided herein are the pharmaceutical compositions produced from the one or more preparations. Also provided herein are methods of producing the pharmaceutical composition from the one or more preparations. 1. A method of preventing , treating or managing a respiratory disease and/or a viral infection , comprising administering to a subject in need of such prevention , treatment , or management a pharmaceutical composition produced from preparations comprising:{'i': 'Illicium verum', '(i) a preparation of the fruit of ; and'}{'i': Sclerotium', 'Poria cocos, '(ii) a preparation of the dried of (Schw.) Wolf, in the weight ratio from 1:1 to 1:10, and'}wherein the pharmaceutical composition comprises a pharmaceutically acceptable carrier.2. The method according to claim 1 , wherein the respiratory disease is pneumonia.3. The method according to claim 1 , wherein the respiratory disease and/or the viral infection is an influenza virus infection.4. The method according to claim 3 , wherein the influenza virus is influenza virus A.5. The method according to claim 1 , wherein the respiratory disease and/or the viral infection is a coronavirus infection.6. The method according to claim 5 , wherein the coronavirus is the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).7. The method according to claim 5 , wherein the coronavirus infection is coronavirus disease 2019 (COVID-19).8. The method according to any one of to claim 5 , wherein the method prevents the respiratory disease and/or the viral infection.9. A method of preventing claim 5 , treating or managing COVID-19 claim 5 , comprising administering to a subject in need of such prevention claim 5 , treatment claim 5 , or management a pharmaceutical ...

Vaporized Medicants and Methods of Use

A method and formulation for delivering a PDE-5 inhibitor in a vaporized state using low temperatures to vaporize the formulation. The formulation contains an inert non-reactive compound that lowers the heat of vaporization of the formulation, and the PDE-5 inhibitor. The formulation may optionally contain glycerin, alcohol, and/or water. Examples of inert non-reactive compounds that can sufficiently lower the heat of vaporization of the formulation include propylene glycol, vegetable glycerin and polysorbate. The formulation can be vaporized using a hand-held low temperature vaporizer or atomizer. 1. A method for delivering medicants through inhalation , comprising: i. an excipient comprising propylene glycol present at approximately 1 percent to approximately 30 percent of the excipient, vegetable glycerin present at approximately 1 percent to approximately 30 percent of the excipient, water present at approximately 0.01 percent to approximately 30 percent of the excipient, and alcohol present at approximately 0.01 percent to approximately 30 percent of the excipient, and', 'ii. phosphodiesterase type 5 inhibitor; and, 'a. acquiring a medicant solution suitable for vaporization, the medicant solution, comprisingb. vaporizing the medicant solution at a temperature ranging from approximately 90 degrees C. to approximately 385 degrees C. such that an effective serving of the medicant solution is provided to a user for inhalation, wherein the step of vaporizing the medicant solution comprises using a vaporizer.2. A method for delivering medicants through inhalation , comprising: i. an excipient comprising an inert non-reactive compound, and', 'ii. a phosphodiesterase type 5 inhibitor; and, 'a. acquiring a medicant solution suitable for vaporization, the medicant solution, comprisingb. vaporizing the medicant solution at a temperature ranging from approximately 90 degrees C. to approximately 385 degrees C. within 2 minutes of activation such that an effective serving ...

Formulation for treating tobacco or psychotrope withdrawal symptoms

The invention relates to a homoeopathic formulation prepared from the six homoeopathic strains tabacum, Nux vomica, Aurum metallicum, Passiflora incarnata, Agnus castus and Lobelia inflata , said homoeopathic formulation having beneficial effects on persons undergoing smoking or psychotropic drug withdrawal.

Chinese medicinal formulation for treating inflammatory bowel disease and the preparation thereof

This invention relates to a Chinese medicinal formulation for the treatment of inflammatory bowel diseases, and a method of preparation thereof. The formulation comprises herbal components selected from a group consisting of Radix Codonopsis (Dangshen), Rhizoma Atractylodis Macrocephalae (Bai Zhu), Sclerotium Poriae Cocos (Fu Ling), Rhizoma Zingiberis Officinalis (Gan Jiang), Radix Paeoniae Alba (Bai Shao) and Rhizoma Coptidis (Huanglian).

HERBAL COMPOSITION FOR TREATING METASTATIC BREAST CANCER

The invention provides a composition comprising a mixture of extracts obtained from , and . The present invention further provides a method for treating metastatic breast cancer in a subject in need thereof, comprising: administering to said subject an pharmaceutically effective amount of the composition. 1. A method for treating metastatic breast cancer in a subject in need thereof , comprising:{'i': Atractylodes macrocephala, Astragalus membranaceus, Taraxacum mongolicum, Poria cocos, Ligusticum chuanxiong, Ligustrum lucidum, Codonopsis pilosula, Glycyrrhiza uralensis, Hedyotis diffusa, Pseudostellaria heterophylla', 'Viola philippica., 'administering to said subject an pharmaceutically effective amount of an aqueous suspension of a composition comprising a mixture of extracts obtained from , and'}2. The method of claim 1 , wherein the extracts are organic solvent extracts.3. The method of claim 2 , wherein the organic solvent is selected from the group consisting of methanol claim 2 , ethanol claim 2 , acetic acid claim 2 , ketone claim 2 , hexane claim 2 , propanol claim 2 , isopropanol and chloroform.4. The method of claim 1 , wherein the extracts are obtained from the whole plants.5. The method of claim 1 , which has a concentration of ingredients as follows:250 mg/mL of Atractylodes macrocephala, 330 mg/mL of Astragalus membranaceus, 500 mg/mL of Taraxacum mongolicum, 330 mg/mL of Poria cocos, 250 mg/mL of Ligusticum chuanxiong, 250 mg/mL of Ligustrum lucidum, 250 mg/mL of Codonopsis pilosula, 160 mg/mL of Glycyrrhiza uralensis, 330 mg/mL of Hedyotis diffusa, 250 mg/mL of Pseudostellaria heterophylla, and 160 mg/mL of Viola philippica.6. The method of claim 1 , wherein the metastatic breast cancer is refractory metastatic breast cancer.7. The method of claim 1 , wherein the composition improves global health status/quality of life (GHS/QOL) scale of the subject.8. The method of claim 1 , wherein the composition increases the level of CD3 claim 1 , CD4/CD8 ...

TRADITIONAL CHINESE MEDICINE COMPOSITION AND PREPARATION METHOD AND USE THEREOF

The present invention relates to the field of traditional Chinese medicine formulation, particularly to a composition and the preparation method and use thereof. The traditional Chinese medicine composition provided by the present invention is produced from raw materials comprising TARAXACI HERBA, GLYCYRRHIZAE RADIX ET RHIZOMA, PLATYCODONIS RADIX, CITRI RETICULATAE PERICARPIUNM and PHYLLANTHI FRUCTUS. The traditional Chinese medicine composition adopts fewer herb medicines. By reasonable combination, the various herbal medicines mutually reinforce in terms of the effects of clearing throat, anti-inflammation and reducing phlegm, exhibit obvious synergistic effect. Pharmacological tests and clinical trials indicate that the traditional Chinese medicine composition has significant throat clear, anti-inflammatory, expectorant effects (p<0.05), and has no obvious toxic and side effects. 1. A traditional Chinese medicine composition , produced from raw materials comprising TARAXACI HERBA , GLYCYRRHIZAE RADIX ET RHIZOMA , PLATYCODONIS RADIX , CITRI RETICULATAE PERICARPIUNM and PHYLLANTHI FRUCTUS.5. A method for producing the traditional Chinese medicine composition according to claim 1 , comprising:subjecting TARAXACI HERBA, GLYCYRRHIZAE RADIX ET RHIZOMA, PLATYCODONIS RADIX, CITRI RETICULATAE PERICARPIUNM and PHYLLANTHI FRUCTUS to mixing, water extraction, alcohol precipitation to obtain the traditional Chinese medicine composition.6. The method according to claim 5 , wherein after water extraction and before alcohol precipitation claim 5 , the method further comprises:pooling and filtering the water extract, and concentrating the filtrate to a concentrate with a solid content of 20-50% at 20° C.7. The method according to claim 5 , wherein the alcohol precipitation is performed by adding ethanol to an ethanol concentration of 50-80% claim 5 , standing for 24 h or more claim 5 , discarding the filtration residue claim 5 , concentrating the supernatant to an extractum with ...

Herbal Tea Products and Methods

An herbal tea product is provided to provide relief from lung and breathing conditions such as asthma. The herbal tea product may include oregano, peppermint, OSHA root, lungwort, eucalyptus, plantain leaf, chaparral, elecampane, lobelia, sage, licorice root, and thyme. The herbal ingredients may be included in equal amounts, such as 5 ounces. The OSHA root, elecampane, and/or licorice root may be crushed. Methods of making and using the herbal tea product are also disclosed. The herbal tea product may be placed into tea bags, and prepared for human consumption by placing the tea bag with herbal tea product in hot water that has been brought to a boil. The herbal tea product may be consumed in appropriate amounts, such as 16 ounces, twice a day for two weeks, and then once a day thereafter.

Compositions and Methods for Managing Weight

The present disclosure provides Diels-Alder adducts of chalcone and prenylphenyl moieties capable of modulating the activity of cannabinoid receptors, and to oligomers of flavan-3-ol capable of modulating fat absorption and storage. Such Diels-Alder adducts of chalcone and prenylphenyl moieties or oligomers of flavan-3-ol can optionally be used in combination with other weight management agents, such as anorectic agents, a lipase inhibitors, other cannabinoid receptor modulators, psychotropic agents, insulin sensitizers, stimulants, or satiety agents, as well as to methods of use thereof such as treating or preventing weight gain or obesity, promoting weight loss, appetite suppression, modifying satiety, or the like. 1MorusMagnolia. A composition , comprising a mixture of a extract enriched for one or more Diels-Alder adducts of a chalcone and a prenylphenyl moiety , a extract , and a Yerba Mate extract.2MorusMorus albaMagnoliaMagnolia officinalisIlex paraguayensis.. The composition according to claim 1 , wherein the extract is from claim 1 , the extract is from claim 1 , and the Yerba Mate extract is from4. The composition of claim 1 , wherein at least two of R claim 1 , R claim 1 , R claim 1 , R claim 1 , R claim 1 , R claim 1 , R claim 1 , R claim 1 , R claim 1 , R claim 1 , R claim 1 , R claim 1 , R claim 1 , R claim 1 , R claim 1 , R claim 1 , R claim 1 , R claim 1 , R claim 1 , R claim 1 , R claim 1 , R claim 1 , Rand Rare hydroxyl.5Morus. The composition according to claim 1 , wherein the extract is enriched for Albanin G claim 1 , Kuwanon G claim 1 , Morusin claim 1 , or any combination thereof.6Magnolia. The composition according to claim 1 , wherein the extract is enriched for magnolol claim 1 , honokiol claim 1 , or both.7. The composition according to claim 1 , wherein the Yerba Mate extract is enriched for caffeine claim 1 , dicaffeoylquinic acid claim 1 , or both.8. The composition according to claim 1 , wherein the composition further comprises a ...

Pharmaceutical Composition for Decreasing The Side Effects of Pancreatic Cancer Drug, and Manufacturing Method and Uses Thereof

The present invention provides a pharmaceutical composition comprising a mushroom, a rhizome, a fruit, a leaf, a flower, an alga, an energy-rich liquid, a salt-rich liquid, an assist agent and an anti-oxide agent. Said pharmaceutical composition has ability to improve autoimmunity, protect from the side-effects caused by chemical cancer drugs and increase the functions of chemical pancreatic cancer drugs. 1. A pharmaceutical kit for treating pancreatic cancer or decreasing the side effects of pancreatic cancer drug , comprising: a pancreatic cancer drug combination and a pharmaceutical composition ,wherein the pancreatic cancer drug combination is selected from the group consisting of a topoisomerase I inhibitor, a topoisomerase II inhibitor, an antimetabolite, and combinations thereof; and{'i': Phellinus linteus,', 'Ganoderma lucidum,', 'Brazilian mushroom,', 'Antrodia', 'Cordyceps sinensis', 'Astragalus,', 'Salvia,', 'Codonopsis,', 'Hedyotis diffusa,', 'Eucommia,', 'Atractylodes,', 'Acanthopanax,', 'Ophiopogon japonicus,', 'Rhodiola', 'Fructus Schisandrae,', 'Schisandra,', 'Gongju chrysanthemum,, 'a pharmaceutical composition, wherein the pharmaceutical composition comprises a mushroom, a rhizome, a fruit, a leaf, a flower, algae, an energy-rich liquid, a salt-rich liquid, an assist agent and an anti-oxide agent; wherein the mushroom is selected from the group consisting of 24-36 grams of 16-24 grams of 16-24 grams of 4-6 grams of camphorata, 4-6 grams of and combinations thereof; wherein the rhizome is selected from the group consisting of 16-24 grams of yellow Fine, 8-12 grams of 8-12 grams of 8-12 grams of 12-18 grams of 12-18 grams of 8-12 grams of 8-12 grams of TCS, 8-12 grams of 8-12 grams of 8-12 grams of rose, 2.4-3.6 grams of Pear licorice and combinations thereof; wherein the fruit seeds 12-18 grams of barley, 8-12 grams of 8-12 grams of 9.6-14.4 grams of germinated rice, 8-12 grams of lotus seed, 8-12 grams of black sesame, 8-12 grams of corn, 8-20 ...

TEA COMPOSITION HAVING EFFICACY FOR PREVENTING OR IMPROVING RESPIRATORY DISEASES, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME

The present invention relates to an anti-respiratory virus composition, especially to a tea composition, and provides a natural composition having efficacy for treating and preventing respiratory virus-related diseases. 1Orostachysjaponicus. An anti-respiratory virus composition containing an extract as an active ingredient.2. The anti-respiratory virus composition of claim 1 , wherein the respiratory virus is one or more selected from the group consisting of adeno virus claim 1 , metapneumo virus claim 1 , rhino virus claim 1 , parainfluenza virus claim 1 , influenza virus claim 1 , respiratory syncytial virus claim 1 , and coronavirus.3. The anti-respiratory virus composition of claim 1 , wherein the respiratory virus is coronavirus.4Orostachys japonicus. The anti-respiratory virus composition of claim 1 , wherein the extract is extracted by using one or more solvent selected from water and alcohols having 1 to 4 carbon atoms.5Adenophora triphylla. The anti-respiratory virus composition of claim 1 , further comprising an extract.6Codonopsis lanceolate, Asparagus cochinchinensis, Polygonatum odoratum, Astragali radix, Taraxacum playtcarpum, Scutellaria baicalensis GeorgiZingiber officinal, Dioscorea batatas, Ginseng urealensis, Glycyrrhiza uralensisZizyphus jujuba, Codonopsis pilosulate radix, Atractylodes japonica, Dryopteris crassirhizoma, Ostericum koreanum, Agastache rugosa, Citrus unshiuSchinzandra chinensis, Lycium chinense, Sophora japonica, Cuscuta semen, Salvia miltiorrhiza, Torilis japonica, Polygala tenuifoliaCurcuma longa.. The anti-respiratory virus composition of claim 1 , further comprising one or more selected from the group consisting of extracts of claim 1 , dry and peel claim 1 , and7. A pharmaceutical composition for an anti-respiratory virus claim 1 , comprising: the anti-respiratory virus composition according to ; and a pharmaceutically acceptable carrier claim 1 , excipient or diluent.8. The pharmaceutical composition of claim 7 , wherein ...

COMPOSITION, PREPARATION METHOD THEREOF, AND APPLICATION THEREOF IN THE PREVENTION AND TREATMENT OF MAMMARY GLAND DISEASE

The present disclosure relates to the technical field of traditional Chinese medicine technology, especially to a composition, a preparation method thereof and an application in the prevention and treatment of mammary gland diseases. The present disclosure provides a composition consisting of Rehmanniae Radix Praeparata, Lycii Fructus, Polygonati Rhizoma, Radix Codonopsis Pilosulae, Paeoniae Radix Alba, Cyperi Rhizoma (processed with vinegar) and Grape Seed. The composition has functions of improving hyperplasia of mammary gland and/or anti-oxidation. Compared with each control group, the composition provided by the present disclosure has the optimal effects, and the effect has statistical differences, indicating that the components in the composition provided by the present disclosure are reasonably arranged and can play a good synergistic effect. Furthermore, the preparation is safe and has no side effects. 4. An extract made from the composition according to .5. A method for preparing the extract according to claim 4 , comprisingextracting Cyperi Rhizoma (processed with vinegar) and Paeoniae Radix Alba with water, concentrating to powder by spraying drying, to give component A;extracting a combination of Rehmanniae Radix Praeparata, Polygonati Rhizoma, Lycii Fructus and Radix Codonopsis Pilosulae by water extraction and alcohol deposit to obtain a precipitation, and drying the precipitation to powder, to give component B;extracting Grape Seed with an alcohol, column separating, gathering effluent fraction of ethanol, and drying the effluent fraction to powder, to give a Grape Seed Extract;and mixing component A, component B and the Grape Seed Extract to give the extract.6. The method according to claim 5 , wherein in the process of water extraction claim 5 , the weight of water is 5-20 times based on a total weight of the medicinal materials claim 5 , the extraction temperature is 80-100° C. claim 5 , the duration is 0.5-4 h claim 5 , and the extraction is ...

CO-ADMINISTRATION COMPOSITION FOR PREVENTING OR TREATING HYPERCHOLESTEROLEMIA, CONTAINING BALLOON-FLOWER EXTRACT OR PLATYCODIN D DERIVED THEREFROM AS ACTIVE INGREDIENT

Provided are a pharmaceutical composition and a method for preventing or treating hypercholesterolemia, the pharmaceutical composition including a extract or Platycodin D derived therefrom, and a statin-class drug as active ingredients. Also disclosed is a method of increasing expression of low-density lipoprotein receptor, the method including the step of treating hepatocytes in vitro with a extract or Platycodin D derived therefrom. 110-. (canceled)11Platycodon grandiflorum. A method of preventing or treating hypercholesterolemia , the method comprising the step of administering , to an individual , a extract or Platycodin D derived therefrom , and a statin-class drug in combination.12. (canceled)13Platycodon grandiflorum. A method of increasing expression of low-density lipoprotein receptor , the method comprising the step of treating hepatocytes in vitro with a extract or Platycodin D derived therefrom.14Platycodon grandiflorum. The method of claim 11 , wherein the extract is extracted using a solvent selected from the group consisting of water claim 11 , Cto Calcohols claim 11 , and mixed solvents thereof.15. The method of claim 11 , wherein the statin-class drug is one or more selected from the group consisting of lovastatin claim 11 , simvastatin claim 11 , pravastatin claim 11 , fluvastatin claim 11 , atorvastatin claim 11 , and cerivastatin.16Platycodon grandiflorum. The method of claim 11 , wherein the extract or Platycodin D derived therefrom is administered in combination with the statin-class drug to have a synergistic effect on preventing or treating hypercholesterolemia.17. The method of claim 11 , wherein the composition increases expression of low-density lipoprotein receptor (LDLR).18. The method of claim 11 , wherein the composition promotes uptake of LDL-cholesterol (LDL-derived cholesterol claim 11 , LDL-C). The present disclosure relates to a composition for combined administration, the composition including a extract or Platycodin D derived ...

Mixture powders of platycodon grandifloras and momordica charantia, and method for producing the powders

A method for preparing mixture powders of platycodon grandiflorus and momordica charantia includes washing at least one year-old platycodon grandiflorus , and momordica charantia wherein the platycodon grandiflorus includes stem, root, and leaf portions thereof; cutting the washed platycodon grandiflorus and momordica charantia ; hot air-drying the cut platycodon grandiflorus and momordica charantia in a dryer at a temperature exceeding a boiling point of hydrogen cyanide gas to remove hydrogen cyanide therefrom; pulverizing the cut and dried platycodon grandiflorus and momordica charantia to prepare platycodon grandiflorus powders and momordica charantia powders; and mixing the platycodon grandiflorus powders and momordica charantia powders to produce the mixture powders of platycodon grandiflorus and momordica charantia.

COMPOSITION FOR PREVENTING, ALLEVIATING OR TREATING STRESS DISEASES, CONTAINING PLATYCODON GRANDIFLORUM EXTRACT AS ACTIVE INGREDIENT

The present disclosure relates to a composition for preventing, alleviating or treating stress diseases, containing a extract as an active ingredient, and, more specifically, to a food composition for preventing or alleviating stress diseases or a pharmaceutical composition for preventing and treating stress diseases, both of which contain a extract and a extract as active ingredients. A method of the present disclosure can be used for the preparation of an agent for treating depression and anxiety, which are stress diseases, with few side effects because of the use of a natural material, and a health functional food having effects of alleviating depression, anxiety and fatigue, which are stress diseases. 1Platycodon grandiflorum. A food composition for preventing or alleviating stress diseases , which comprises a extract as an active ingredient.2Citrus aurantium. The food composition according to claim 1 , wherein the composition further comprises a extract.3Platycodon grandiflorumCitrus aurantium. The food composition according to claim 2 , wherein the composition comprises the and the at a weight ratio of (1-10):(1-10).4. The food composition according to claim 1 , wherein the stress disease is one or more selected from a group consisting of depression claim 1 , anxiety and fatigue.5Platycodon grandiflorum. A pharmaceutical composition for treating stress diseases claim 1 , which comprises a extract as an active ingredient.6Citrus aurantium. The pharmaceutical composition for treating stress diseases according to claim 5 , wherein the composition further comprises a extract.7. (canceled)8. (canceled)9. (canceled)10Platycodon grandiflorum. A method for treating stress diseases wherein an effective amount of a extract is administered to an individual in need thereof.11Citrus aurantium. The method for treating stress diseases according to claim 10 , wherein a extract is further administered.12Platycodon grandiflorumCitrus aurantium. The method for treating stress ...

Ceramide Production-Accelerating Agent

The present invention provides a pharmaceutical composition or a cosmetic product which can accelerate production of ceramide in cells. The ceramide production-accelerating agent contains a plant selected from the group consisting of , and , or an extract thereof as an active ingredient. Further, the present invention provides a moisturizing agent containing a plant selected from the group consisting of and , or an extract thereof as an active ingredient. 18-. (canceled)9Angelicae Dahuricae Radix, Rehmanniae Radix, Atractylodis Rhizoma, Glycyrrhizae Radix, Rhei Rhizoma, Bletilla Tuber, Polygoni Multiflori Radix, Platycodi Radix, Leonuri HerbaDioscoreae Rhizoma. A method for accelerating ceramide production in a normal human keratinocyte comprising administering a plant selected from the group consisting of , and , or an extract thereof , as an active ingredient to the normal human keratinocyte.10Angelicae Dahuricae Radix, Atractylodis Rhizoma, Bletilla Tuber, Polygoni Multiflori Radix, Platycodi Radix, Leonuri HerbaDioscoreae Rhizoma. The method according to claim 9 , wherein an extract of claim 9 , or is administered claim 9 , and the extract is a petroleum ether extract prepared by using a petroleum ether as an extraction solvent.11Rehmanniae RadixGlycyrrhizae Radix. The method according to claim 9 , wherein an extract of or is administered claim 9 , and the extract is an ethanol extract prepared by successively using a petroleum ether and ethanol as extraction solvents.12Rhei Rhizoma. The method according to claim 9 , wherein an extract of is administered claim 9 , and the extract is a water extract prepared by successively using a petroleum ether claim 9 , ethanol claim 9 , and water as extraction solvents.13Leonuri HerbaDioscoreae Rhizoma. A method of moisturizing skin claim 9 , comprising administering a plant selected from the group consisting of and claim 9 , or an extract thereof claim 9 , as an active ingredient to the skin.14Leonuri HerbaDioscoreae ...

PHARMACEUTICAL COMPOSITION FOR TREATING CARDIO-CEREBROVASCULAR DISEASES AND METHOD FOR PREPARING THE SAME

A pharmaceutical composition, including, parts by weight of: 100-170 of a ginkgo flavone, 40-100 of a jujube extract, 100-200 of an extract of a peel of , 30-60 of a saponin of , 50-100 of a saponin of American ginseng, 40-70 of a saponin of , 20-50 of hirudin, 3-10 of a coenzyme Q10, 40-100 of a longan extract, 20-50 of a modified starch, 100-150 of a carthamin, 100-150 of an extract of peach kernel, 30-50 of a gastordin, 120-200 of a salvianolic acid, 40-90 of an extract of , 100-150 of a saponin of , 0-50 of a black sesamin, and 0-50 of an astaxanthin. 1Trichosanthes kirilowii,Codonopsis,Radix astragalu,Ligusticum chuanxiong,Panax notoginseng,. A pharmaceutical composition , comprising: 100-170 parts by weight of a ginkgo flavone , 40-100 parts by weight of a jujube extract , 100-200 parts by weight of an extract of peel of 30-60 parts by weight of a saponin of 50-100 parts by weight of a saponin of American ginseng , 40-70 parts by weight of a saponin of 20-50 parts by weight of hirudin , 3-10 parts by weight of a coenzyme Q10 , 40-100 parts by weight of a longan extract , 100-150 parts by weight of a carthamin , 100-150 parts by weight of an extract of peach kernel , 0-50 parts by weight of a gastordin , 120-200 parts by weight of a salvianolic acid , 40-90 parts by weight of an extract of 100-150 parts by weight of a saponin of 0-50 parts by weight of a black sesamin , and 0-50 parts by weight of an astaxanthin.2. The pharmaceutical composition of claim 1 , further comprising 20-50 parts by weight of a modified starch.3. The pharmaceutical composition of claim 2 , wherein a dose of the modified starch is 30-40 parts by weight.4. The pharmaceutical composition of claim 2 , wherein a dose of the jujube extract is 50-80 parts by weight.5Trichosanthes kirilowii. The pharmaceutical composition of claim 2 , wherein a purity of the ginkgo flavone is equal to or larger than 98% claim 2 , and a dose of the ginkgo flavone is 150-170 parts by weight; and a dose of the ...

Plant extraction method

A plant extraction method includes the following steps: 1) preparation of a crude plant extraction solution; 2) separation of the crude extraction solution through a cation resin and an optional anion resin to obtain a collection solution; 3) concentration of the collection solution obtained in step 2); 4) alcohol precipitation of the concentration solution obtained in step 3); and optionally, step 5) concentration and drying. The method can effectively reduce the content of heavy metals in an extract, and reduce the amount of ethanol used in extraction, thereby improving the product quality and lowering the production cost, and the efficiency and safety of industrial production are improved. The extract obtained by this method can be used to prepare drugs for lowering blood lipid, treating abnormal glucose tolerance, treating diseases related to abnormal blood glucose, or regulating intestinal flora, and can be processed into food products, health-care products or drinks.

POWDER FOR REGULATING INTESTINAL FLORA AND PROTECTING GASTRIC MUCOSA, PREPARATION METHOD AND USE THEREOF

The present disclosure relates to the field of health care products. The present disclosure provides a powder which is prepared from xylooligosaccharide, isomaltooligosaccharide, mannitol, inulin, RADIX CODONOPSIS, FRUIT BODY HERICIUM ERINACEUS extract, RHIZOMA DIOSCOREA OPPOSITA, SCLEROTIUM PORIA, SEMEN DOLICHOS, PERICARPIUM CITRUS, FRUCTUS AMOMUM and RHIZOMA MACROCEPHALA. All raw materials are from natural Chinese herbal medicine. No additives are added. The method for preparing the powder in the present disclosure is simple and suitable for large-scale production. Also, it is easy to be carried. Experiment data shows that the powder described in the present disclosure has the function of relieving the gastric mucosal injury by reducing the acute gastric mucosal injury induced by ethanol effectively and has the function of regulating gastric mucosa. Therefore, the powder could be used to prepare the health care product which has the function of regulating gastrointestinal tract and protecting the gastric mucosa. 1. A powder , which is prepared from xylooligosaccharide , isomaltooligosaccharide , mannitol , inulin , RADIX CODONOPSIS , FRUIT BODY HERICIUM ERINACEUS extract , RHIZOMA DIOSCOREA OPPOSITA , SCLEROTIUM PORIA , SEMEN DOLICHOS , PERICARPIUM CITRUS , FRUCTUS AMOMUM and RHIZOMA MACROCEPHALA.2. The powder according to claim 1 , wherein the mass ratio of inulin claim 1 , xylooligosaccharide claim 1 , isomaltooligosaccharide claim 1 , mannitol claim 1 , RADIX CODONOPSIS claim 1 , FRUIT BODY HERICIUM ERINACEUS extract claim 1 , RHIZOMA DIOSCOREA OPPOSITA claim 1 , SCLEROTIUM PORIA claim 1 , SEMEN DOLICHOS claim 1 , PERICARPIUM CITRUS claim 1 , FRUCTUS AMOMUM and RHIZOMA MACROCEPHALA is (10˜30):(10˜30):(10˜20):(10˜20):(3˜10):(3˜10):(3˜8):(3˜8):(2˜5):(2˜5):(1˜5):(1˜5).3. The powder according to claim 1 , wherein the mass ratio of inulin claim 1 , xylooligosaccharide claim 1 , isomaltooligosaccharide claim 1 , mannitol claim 1 , RADIX CODONOPSIS claim 1 , FRUIT ...

Vaporized Medicants and Methods of Use

A method and formulation for delivering a motion sickness antidote in a vaporized state using low temperatures to vaporize the formulation. The formulation contains an inert non-reactive compound that lowers the heat of vaporization of the formulation, and the motion sickness antidote. The formulation may optionally contain glycerin, alcohol, and/or water. Examples of inert non-reactive compounds that can sufficiently lower the heat of vaporization of the formulation include propylene glycol, vegetable glycerin and polysorbate. The formulation can be vaporized using a hand-held low temperature vaporizer or atomizer. 1. A method for delivering medicants through inhalation , comprising: i) an excipient comprising propylene glycol present at approximately 1 percent to approximately 30 percent of the excipient, vegetable glycerin present at approximately 1 percent to approximately 30 percent of the excipient, water present at approximately 0.01 percent to approximately 30 percent of the excipient, and alcohol present at approximately 0.01 percent to approximately 30 percent of the excipient, and', 'ii) diphenhydramine; and, 'a) acquiring a medicant solution suitable for vaporization, the medicant solution, comprisingb) vaporizing the medicant solution at a temperature ranging from approximately 90 degrees C. to approximately 385 degrees C. such that an effective serving of the medicant solution is provided to a user for inhalation.2. The method of claim 1 , wherein the step of vaporizing the medicant solution comprises using a vaporizer.3. method for delivering medicants through inhalation claim 1 , comprising: i) an excipient comprising an inert non-reactive compound, and', 'ii) a motion sickness antidote; and, 'a) acquiring a medicant solution suitable for vaporization, the medicant solution, comprisingb) vaporizing the medicant solution at a temperature ranging from approximately 90 degrees C. to approximately 385 degrees C.4. The method of claim 2 , wherein the step ...

COMPOSITION FOR IMPROVING OR PROMOTING HAIR GROWTH CONTAINING, AS ACTIVE INGREDIENTS, PHOTOSENSITIZER IRRADIATED WITH LIGHT AND PEPTIDE, AND METHOD USING SAME

The present invention relates to a composition for improving or promoting hair growth, which contains, as an active ingredient, a photosensitizer-peptide conjugate, and to a method for screening for the hair growth promoter using the active ingredients. ALA, which is the photosensitizer of the present invention, is preferably activated by LED radiation, and more preferably activated by radiation having a long wavelength of 650 to 675 nm. The peptide of the present invention is a peptide in which 3 to 7 amino acid residues are incorporated (most preferably, glycine-histidine-lysine), and may cooperate with the photosensitizer to enable very superior hair growth improving or promoting effects using light radiation. Further, the composition of the present invention may exhibit further superior effects when natural extracts (for example, extracts, extracts or extracts) are added. Thus, the composition of the present invention can be significantly advantageously applied to drugs, quasi-drugs, and cosmetics. 1. A composition for improving or promoting hair growth , which contains , as an active ingredient , a peptide coupled to a photosensitizer (photosensitizer-peptide).2. The composition of claim 1 , characterized in that the photosensitizer is 5-aminolevulinic acid (ALA) claim 1 , 5-ALA-induced protoporphyrin IX claim 1 , hematophorphyrin (HpD) claim 1 , Photogem claim 1 , tin etiopurpurin (SnET2) claim 1 , mono-1-aspartyl chlorin e6 (NPe6) claim 1 , benzoporphyrin derivative (BPD) claim 1 , meso-tetra-(hydroxyphenyl) chlorin (mTHPC) claim 1 , radachlorin claim 1 , aluminum tetrasulfophthalocyanine (ALPcS4) claim 1 , or meso-tetra(sulphonatophenyl)porphine (TPPS).3. The composition of claim 2 , characterized in that the photosensitizer is 5-aminolevulinic acid (ALA).4. The composition of claim 1 , characterized in that the photosensitizer is activated by light-emitting diode (LED) radiation.5. The composition of claim 4 , characterized in that a wavelength of the LED ...

FEED ADDITIVE FOR SWINE AND FEED COMPOSITION CONTAINING THE SAME

A feed additive for swine consists of following ingredients measured by weight: 20-50 sour jujubes, 10-18 radix bupleuri, 6-20 10-20 honeysuckles, 10-20 roots, 10-18 6-9 red jujubes, 10-20 and 30-60 cactuses. The disclosure further provides a feed composition for swine with the above feed additive. The above-mentioned feed additive for swine is effective in preventing hog cholera, convenient in use, no toxicity, side effects or medical residue, which benefits human health.

FEED ADDITIVE FOR SWINE AND FEED COMPOSITION CONTAINING THE SAME

A feed additive for swine consists of following ingredients measured by weight: 20-50 sour jujubes, 10-18 radix bupleuri, 6-20 codonopsis pilosula, 10-20 honeysuckles, 10-20 isatis roots, 3-6 astragalus propinquus, 10-20 myrica rubra and 30-60 cactuses. The disclosure further provides a feed composition for swine with the above feed additive. The above-mentioned feed additive for swine is effective in preventing hog cholera, convenient in use, no toxicity, side effects or medical residue, which benefits human health. 1. A feed additive for swine , wherein the feed additive for swine consists of following ingredients measured by weight: 20-50 sour jujubes , 10-18 radix bupleuri , 6-20 codonopsis pilosula , 10-20 honeysuckles , 10-20 isatis roots , 3-6 astragalus propinquus , 10-20 myrica rubra and 30-60 cactuses.2. The feed additive for swine according to claim 1 , wherein the feed additive for swine consists of 35 sour jujubes claim 1 , 16 radix bupleuri claim 1 , 12 codonopsis pilosula claim 1 , 15 honeysuckles claim 1 , 15 isatis roots claim 1 , 5 astragalus propinquus claim 1 , 15 myrica rubra and 50 cactuses.3. A feed composition for swine claim 1 , comprising a main feed and an additive claim 1 , wherein the additive is processed by mixing claim 1 , grinding claim 1 , sifting following ingredients measured by weight: 20-50 sour jujubes claim 1 , 10-18 radix bupleuri claim 1 , 6-20 codonopsis pilosula claim 1 , 10-20 honeysuckles claim 1 , 10-20 isatis roots claim 1 , 3-6 astragalus propinquus claim 1 , 10-20 myrica rubra and 30-60 cactuses.4. The feed composition for swine according to claim 3 , wherein the main feed comprises at least one of an animal protein product claim 3 , marine product claim 3 , milk product claim 3 , grain product claim 3 , plant protein product and processed grain by-product.5. The feed composition for swine according to claim 3 , wherein a ration of the main feed for swine and the additive is 500:3.6. A process for feeding swine ...

FEED ADDITIVE FOR SWINE AND FEED COMPOSITION CONTAINING THE SAME

A feed additive for swine consists of following ingredients measured by weight: 20-50 sour jujubes, 10-18 , 6-20 , 10-20 honeysuckles, 10-20 roots, 4-8 , 3-6 liquorice, 10-20 and 30-60 cactuses. The disclosure further provides a feed composition for swine with the above feed additive. The above-mentioned feed additive for swine is effective in preventing hog cholera, convenient in use, no toxicity, side effects or medical residue, which benefits human health. 1radix bupleuri,codonopsis pilosulaisatisanemarrhena asphodeloides,myrica rubra. A feed additive for swine , wherein the feed additive for swine consists of following ingredients measured by weight: 20-50 sour jujubes , 10-18 6-20 , 10-20 honeysuckles , 10-20 roots , 4-8 3-6 liquorice , 10-20 and 30-60 cactuses.2radix bupleuricodonopsis pilosulaisatisanemarrhena asphodeloidesmyrica rubra. The feed additive for swine according to claim 1 , wherein the feed additive for swine consists of 35 sour jujubes claim 1 , 16 claim 1 , 12 claim 1 , 15 honeysuckles claim 1 , 15 roots claim 1 , 6 claim 1 , 4 liquorice claim 1 , 15 and 50 cactuses.3radix bupleuri,codonopsis pilosula,isatisanemarrhena asphodeloides,myrica rubra. A feed composition for swine claim 1 , comprising a main feed and an additive claim 1 , wherein the additive is processed by mixing claim 1 , grinding claim 1 , sifting following ingredients measured by weight: 20-50 sour jujubes claim 1 , 10-18 6-20 10-20 honeysuckles claim 1 , 10-20 roots claim 1 , 4-8 3-6 liquorice claim 1 , 10-20 and 30-60 cactuses.4. The feed composition for swine according to claim 3 , wherein the main feed comprises at least one of an animal protein product claim 3 , marine product claim 3 , milk product claim 3 , grain product claim 3 , plant protein product and processed grain by-product.5. The feed composition for swine according to claim 3 , wherein a ration of the main feed for swine and the additive is 500:3.6radix bupleuri,codonopsis pilosula,isatisanemarrhena ...

USE OF COMPOSITION IN PREPARING HEALTH CARE PRODUCTS OR MEDICINES FOR PREVENTING AND TREATING ALLERGIC DISEASES

The present invention relates to use of a composition in the manufacture of health care products or medicaments for prevention and treatment of allergic diseases. The composition is made from raw materials comprising 5 to 200 parts by weight of Ganoderma, 5 to 150 parts by weight of Radix Panacis Quinquefolii or Radix Et Rhizoma Ginseng, 1 to 90 parts by weight of fermented powder and/or 1 to 120 parts by weight of Cordyceps, or is a composition made from water and/or alcohol extracts of the above raw materials as active components. The allergic diseases include allergic rhinitis, allergic dermatitis, urticaria, and/or allergic asthma. 1Cordyceps sinensis. A method of preventing or treating allergic diseases , comprising the step of administering to a subject in need thereof a composition made from raw materials comprising Ganoderma , Radix Panacis Quinquefolii or Radix Et Rhizoma Ginseng , fermented powder and/or Cordyceps.2. The method of claim 1 , characterized in that the composition further comprise one or more of Flos Rosae Rugosae claim 1 , Ganoderma spore powder claim 1 , Ganoderma spore oil claim 1 , Radix Pseudostellariae claim 1 , Folium Ginseng claim 1 , Radix Codonopsis claim 1 , and Radix Astragali.3Cordyceps sinensis. The method of claim 1 , characterized in that the composition is made from raw materials comprising 5 to 200 parts by weight of Ganoderma claim 1 , 5 to 150 parts by weight of Radix Panacis Quinquefolii or Radix Et Rhizoma Ginseng claim 1 , 1 to 90 parts by weight of fermented powder and/or 1 to 120 parts by weight of Cordyceps.4Cordyceps sinensis. The method of claim 3 , characterized in that the composition is made from the following raw materials: 5 to 200 parts by weight of Ganoderma claim 3 , 5 to 150 parts by weight of Radix Panacis Quinquefolii or Radix Et Rhizoma Ginseng claim 3 , 1 to 90 parts by weight of fermented powder and/or 1 to 120 parts by weight of Cordyceps.5Cordyceps sinensis. The method of claim 3 , characterized in ...

COMPOSITION FOR PREVENTING AND TREATING AIDS AND PREPARATION METHOD THEREOF

The present invention relates to a pharmaceutical composition made from the following raw materials or from water and/or alcohol extracts of the following raw materials in parts by weight: 5 to 200 parts of Ganoderma, 5 to 150 parts of Radix Panacis Quinquefolii or Radix Et Rhizoma Ginseng, 1 to 90 parts of fermented powder and/or 1 to 120 parts of , and optionally one or more of 5 to 90 parts of Flos Rosae Rugosae, 5 to 150 parts of Ganoderma spore powder, 10 to 400 parts of Radix Pseudostellariae, 3 to 400 parts of Radix Codonopsis and 3 to 400 parts of Radix Astragali. Clinical trials demonstrate that the composition can significantly reduce HIV virus load in patients, increase the number of CD4+ cells, enhance the immunity of patients, has no considerable toxic and side effects, and is suitable for long-term use. 1Cordyceps sinensisCordyceps.. A composition for preventing and treating AIDS , characterized in that the composition is substantially made from the following raw materials or from water and/or alcohol extracts of the following raw materials as active components: 5 to 200 parts by weight of Ganoderma , 5 to 150 parts by weight of Radix Panacis Quinquefolii or Radix Et Rhizoma Ginseng , 1 to 90 parts by weight of fermented powder and/or 1 to 120 parts by weight of2Cordyceps sinensisCordyceps.. The composition according to claim 1 , wherein the active components comprise 20 to 120 parts by weight of Ganoderma claim 1 , 10 to 90 parts by weight of Radix Panacis Quinquefolii or Radix Et Rhizoma Ginseng claim 1 , 3 to 60 parts by weight of fermented powder and/or 3 to 90 parts by weight of3Cordyceps sinensisCordyceps.. The composition according to claim 1 , characterized by wherein the active components comprise 40 parts by weight of Ganoderma claim 1 , 30 parts by weight of Radix Panacis Quinquefolii or Radix Et Rhizoma Ginseng claim 1 , 20 parts by weight of fermented powder and/or 6.7 parts by weight of4. The composition according to claim 1 , ...

Vaporized Medicants and Methods of Use

A method and formulation for delivering an active analgesic compound, such as an opiate, in a vaporized state using low temperatures to vaporize the formulation. The formulation contains an inert non-reactive compound that lowers the heat of vaporization of the formulation, and the active compound. The formulation may optionally contain glycerin, alcohol, and/or water. Examples of inert non-reactive compounds that can sufficiently lower the heat of vaporization of the formulation include propylene glycol, vegetable glycerin and polysorbate. The formulation can be vaporized using a hand-held low temperature vaporizer or atomizer. 1. A method for delivering medicants through inhalation , comprising: i. an excipient comprising propylene glycol present at approximately 1 percent to approximately 30 percent of the excipient, vegetable glycerin present at approximately 1 percent to approximately 30 percent of the excipient, water present at approximately 0.01 percent to approximately 30 percent of the excipient, and alcohol present at approximately 0.01 percent to approximately 30 percent of the excipient, and', 'ii. fentanyl; and, 'a. acquiring a medicant solution suitable for vaporization, the medicant solution, comprisingb. vaporizing the medicant solution at a temperature ranging from approximately 90 degrees C. to approximately 385 degrees C. such that an effective serving of the medicant solution is provided to a user for inhalation, wherein the step of vaporizing the medicant solution comprises using a vaporizer.2. A method for delivering medicants through inhalation , comprising: i. an excipient comprising an inert non-reactive compound, and', 'ii. an analgesic; and, 'a. acquiring a medicant solution suitable for vaporization, the medicant solution, comprisingb. vaporizing the medicant solution at a temperature ranging from approximately 90 degrees C. to approximately 385 degrees C. within 2 minutes of activation such that an effective serving of the analgesic is ...

Pharmaceutical composition for treatment of depression and preparation method thereof

Disclosed is a pharmaceutical composition for the treatment of Depression, wherein the pharmaceutical composition is comprised of the following herbs in weight parts: 2-10 parts Ramulus Cinnamomi, 2-10 parts Rhizoma Zingiberis, 2-10 parts Fructus Schisandrae Chinensis, 2-8 parts Semen Ziziphi Spinosae, 2-8 parts Radix Codonopsis, 1-3 parts Rhizoma Dioscoreae, 0.5-2.5 parts Flos Inulae, 1-3 parts Caulis Bambusae in Taenia, 1-3 parts Fructus Trichosanthis, 1.5-4 parts Caulis Polygoni Multiflori, 1.5-4 parts Radix Ophiopogonis, 2-8 parts Radix Rehmanniae, 1.5-4 parts Cortex Moutan Radicis, 0.5-2.5 parts Fructus Gardeniae, 0.5-2.5 parts Herba Lophatheri, and 0.2-1.5 parts Folium Sennae. Also disclosed is a method for preparing the pharmaceutical composition as described above for treatment of depression.

Solid Beverage for Conditioning Blood Stasis Constitution and Method for Producing the Same

The present application discloses a solid beverage for conditioning blood stasis constitution. The solid beverage comprises the following components in parts by weight: 21-55 parts of hawthorn, 9-33 parts of peach seed, 9-33 parts of gingko, 5-21 parts of , 9-33 parts of dried tangerine peel, 0.5-4 parts of cinnamon, 9-33 parts of the root of kudzu vine, 2-21 parts of , 10-29 parts of dextrin, 7-25 parts of maltodextrin, 8-26 parts of soluble starch and 0.05-0.2 parts of aspartame. The solid beverage of the present application is simple and convenient to prepare, the raw materials used are all medicinal materials with dual-purpose of drug and food, and the auxiliary materials used also meet the national standard GB2760-2011 (the National Food Safety Standard for Food Additive Use). Thus, the solid beverage is safe to consume and good in taste, and has certain effects on the improvement of blood stasis constitution, and the production process thereof is suitable for industrial mass production. 1platycodon grandiflorus,dahurian angelica,. A solid beverage for conditioning blood stasis constitution , characterized by comprising the following components in parts by weight: 21-55 parts of hawthorn , 9-33 parts of peach seed , 9-33 parts of gingko , 5-21 parts of 9-33 parts of dried tangerine peel , 0.5-4 parts of cinnamon , 9-33 parts of the root of kudzu vine , 2-21 parts of 10-29 parts of dextrin , 7-25 parts of maltodextrin , 8-26 parts of soluble starch and 0.05-0.2 parts of aspartame.2platycodon grandiflorus,dahurian angelica,. The solid beverage for conditioning blood stasis constitution according to claim 1 , characterized by comprising the following components in parts by weight: 30-44 parts of hawthorn claim 1 , 15-23 parts of peach seed claim 1 , 17-28 parts of gingko claim 1 , 9-17 parts of 15-28 parts of dried tangerine peel claim 1 , 1-3 parts of cinnamon claim 1 , 14-23 parts of the root of kudzu vine claim 1 , 8-17 parts of 19-24 parts of dextrin claim 1 , ...

HERBAL COMPOSITION FOR TREATMENT OF BACK PAIN

The present invention encompasses compositions and methods for reducing back pain in a subject. 1. A method for reducing back pain in a subject , the method comprisinga) identifying a subject in need of treatment for back pain, and{'i': arnica', 'Arnica montana', 'Rosmarinus officinalis', 'Lavendula officinalis', 'lobelia', 'Lobelia inflata, 'b) administering composition A to the subject, wherein composition A comprises witch hazel extract and leaves, (), rosemary (), lavender (), and ().'}2lobeliaSymphytum officnate. The method of claim 1 , wherein the is substituted with comfrey ().3Zingiber officinale. The method of claim 1 , wherein the lavender is substituted with ginger ().4. The method of claim 1 , wherein the subject has back pain that has not resolved following a rest period.5. The method of claim 4 , wherein the rest period is about 30 days.6. The method of claim 1 , wherein the back pain is refractory back pain.7. The method of claim 1 , wherein the back pain is eliminated.8. The method of claim 1 , wherein the subject is an equine.9. The method of claim 8 , wherein the back pain is in the third quadrant of an equine.10. The method of claim 1 , wherein the composition is administered daily.11. The method of claim 1 , wherein the composition is administered for at least a week.12. The method of claim 1 , wherein the composition is administered for two weeks.13. The method of claim 1 , wherein the composition is administered for greater than two weeks.14. The method of claim 1 , wherein the composition is administered during known risk factors for back pain selected from the group consisting of heavy exercising claim 1 , high stress activities claim 1 , traveling claim 1 , training claim 1 , and competition.15. The method of claim 1 , wherein the composition is administered following exercise.16. The method of claim 1 , further comprising administering standard treatments for back pain. This application claims the benefit of U.S. Provisional Application No. ...

Herbal Composition and a Method for the Treatment of Hyperlipidemia Caused by Excessive Consumption of Lamb

A composition and a method for treating hyperlipidemia caused by excessive consumption of lamb. The composition comprises in various parts: root of anhwei barberry, folium isatidis, garden erphorbia herb, aster ageratoides, Vietnamese sophora root, codonopsis ianceolata, all-grass of snakefoot clubmoss, apanese stephania root, amur barberry root, thymifoious euphorbia herb, puff-ball, meadowrue root and rhizome, cottonrose hibiscus flower, common lantana leaf, herba orostachyos, Japanese dock root, pubescent holly root, Chinese brake herb, fruit of tree-of-heaven ailanthus, Chinese iris seed, European verbena herb, datura seed, wild buckwheat rhizome, filliform cassytha herb, fig, radix cynanchi atrati, bittersweet herb, Chinese pulsatilla root, spreading hedyotis herb, figwort root, herb of hygrometric boea, radix ardisiae crenatae, sowthistle tasselflower herb, weeping forsythia, roughhaired holly root, tree peony bark, membrane of chicken gizzard, carrot, medicated leaven, and radix glycyrrhizae. The method comprises weighing each herb, blending them into water and soak, boiling the mixture, and filtering the residue. 1. A composition for treating hyperlipidemia caused by excessive consumption of lamb , wherein the hyperlipidemia refers to lipid metabolism disorders , abnormal fat metabolism or transport , too high lipid concentration in plasma , including total cholesterol and triglyceride levels , higher than those of normal people of the same age , the said composition comprising:i. root of anhwei barberry in an amount of 6-12 parts by weight,ii. folium isatidis in an amount of 5-10 parts by weight,iii. garden erphorbia herb in an amount of 6-12 parts by weight,iv. aster ageratoides in an amount of 4-8 parts by weight,v. Vietnamese sophora root in an amount of 5-10 parts by weight,vi. codonopsis ianceolata in an amount of 6-12 parts by weight,vii. all-grass of snakefoot clubmoss in an amount of 6-12 parts by weight,viii. apanese stephania root in an amount of ...

Herbal Composition for Shrimp Disease

A composition of herbal medicine which can be used for shrimp disease treatment, includes the following ingredients: Lour, , composition X and fishmeal, crude protein, soymeal, powder, dextrin, glucose and minerals. The composition is used in manufacturing three different medicaments and for the different medicaments, the composition X includes one or more ingredients of astragalus, vitexin flower, elephantopus flower and leaf. The composition and the medicaments are effective in treating the shrimp infectious disease, protozoa and improving the shrimp immune system. 1Lobelia chinensisCoptis chinensis. A composition used as prophylaxis and/or therapy of shrimp disease , the composition containing: Lour , elephantopus and and adjuvant.2. A composition as claimed in claim 1 , wherein the adjuvant containing glucose and minerals3. A composition as claimed in claim 1 , wherein the composition is in the form of a granular formulation claim 1 , liquid formulation and paste formulation.4. A composition as claimed in claim 1 , wherein the composition is used in preparing and/or manufacturing shrimp disease prophylactic and/or therapeutic medicaments.5Lobelia chinensisCoptis chinensis. A process for preparing the composition useful as prophylactic and/or therapeutic of shrimp disease claim 1 , said process comprising: i) obtaining extracts from Lour claim 1 , obtaining filtrate by filtering the extracts claim 1 , obtaining paste from the filtrate claim 1 , stirring the paste and adding in ethanol claim 1 , filtering the supernatant liquid and retrieving the ethanol claim 1 , condensing the supernatant liquid to a first paste; obtaining extracts from elephantopus and with ethanol; filtering the extract with ethanol; condensing the filtrate to a second paste; combining said first paste and said second paste to a third paste; ii) heating water to 80-90° C. claim 1 , adding in glucose claim 1 , minerals and quickly stir to completely dissolve claim 1 , adding in paste C obtained ...

Pharmaceutical Composition and Methods for Modulating Immune System, Preventing, Pretreating and/or Treating Cancers

This invention provides a pharmaceutical composition for modulating immune system comprising at least one polysaccharide extracted from , or mixtures thereof, and their extraction process. The present invention further relates to a method of modulating immune system by applying said pharmaceutical composition to a subject suffering from cancers, and a method of preventing and/or pretreating and/or treating cancers in the subject, where said method comprises applying said pharmaceutical composition before/during chemotherapy. 1Radix AstragaliRadix CodonopsisGandoderma sinense. A method of treating mammary cancer comprising administering an effective amount of a pharmaceutical composition in combination with at least one chemotherapeutic agent in an effective dose to a subject in need thereof , said pharmaceutical composition comprising extract , extract , extract , or a mixture thereof.2. The method of claim 1 , wherein the mixture has a molecular weight in the range of 500-2 claim 1 ,500 kDa claim 1 , 600-2 claim 1 ,000 kDa claim 1 , or 700-1 claim 1 ,900 kDa.3. The method of claim 1 , wherein the mixture consists of a constituent selected from the group of glucose claim 1 , galactose claim 1 , mannose claim 1 , rhamnose claim 1 , arabinose claim 1 , and combinations thereof.4. The method of claim 3 , wherein any two of the constituents is in the molar ratio ranging from 1:30 to 30:1 claim 3 , 1:20 to 20:1 claim 3 , or 1:10 to 10:1.5. The method of claim 1 , wherein the mixture consists of glucose claim 1 , galactose and mannose as the constituents in the molar ratio of 4.7:27.1:1.0.6. The method of claim 1 , wherein the mixture consists of rhamnose claim 1 , arabinose claim 1 , glucose claim 1 , galactose and galacturonic acid as the constituents in the molar ratio of 0.03:1.00:0.27:0.36:0.30.7. The method of claim 1 , wherein the mixture consists mainly of glucose and trace amounts of galactose and mannose as the constituents.8. The method of claim 1 , wherein the ...

COMPOSITION FOR PREVENTING AND TREATING MUSCLE DISEASES OR IMPROVING MUSCULAR FUNCTION, CONTAINING PLATYCODON GRANDIFLORUM EXTRACT

The present invention relates to a composition for preventing and treating muscle diseases or improving muscular function, containing a extract. More specifically, the present invention relates to: a pharmaceutical composition for preventing and treating muscle diseases, containing a extract; a food composition for preventing muscle diseases or improving muscular function; or a cosmetic for improving muscular function. The extract of the present invention increases muscle formation by inducing muscular protein synthesis and muscle cell differentiation. Therefore, the extract is a natural product so as to be used safely without side effects, thereby being usable as an active ingredient of a pharmaceutical, food, or cosmetic composition exhibiting an excellent effect in preventing and treating muscle diseases or improving muscular function. 1Platycodon grandiflorum. A pharmaceutical composition for preventing or treating a muscle disease , the composition comprising a extract as an active ingredient.2Platycodon grandiflorum. The pharmaceutical composition according to claim 1 , wherein the extract is an extract obtained by using at least one solvent selected from the group consisting of water claim 1 , an organic solvent having 1 to 6 carbon atoms claim 1 , a subcritical fluid claim 1 , a supercritical fluid claim 1 , and a mixture thereof.3. The pharmaceutical composition according to claim 2 , wherein the organic solvent having 1 to 6 carbon atoms is selected from the group consisting of alcohol having 1 to 6 carbon atoms claim 2 , acetone claim 2 , ether claim 2 , benzene claim 2 , chloroform claim 2 , ethyl acetate claim 2 , methylene chloride claim 2 , hexane claim 2 , cyclohexane claim 2 , and petroleum ether.4. The pharmaceutical composition of any one of to claim 2 , wherein the muscle disease is selected from the group consisting of atony claim 2 , muscular atrophy claim 2 , muscular dystrophy claim 2 , muscular degeneration claim 2 , muscular spasticity ...

Chinese Herbal Oral Paste for Conditioning Phlegm-dampness Constitution and Processing Method thereof

The present application discloses a Chinese herbal oral paste for conditioning phlegm-dampness constitution. The Chinese herbal oral paste includes the following raw material components: tangshen, prepared largehead atractylodes rhizome, prepared atractylodes rhizome, turmeric, unprocessed germinated barley, villous amomum fruit, coix seed, kelp, peach seed, tall gastrodia tuber, fuling, dried tangerine peel, seaweed, bitter apricot seed, cardamon fruit, perilla fruit, oriental waterplantain rhizome, ricepaperplant pith, Chinese waxgourd peel, kudzu vine root, unprocessed hawthorn fruit, milkvetch root, rice beans, lotus leaf, fortune eupatorium herb leaf, unprocessed cattail pollen, unprocessed rhubarb root and rhizome, inner membrane of chicken gizzard, white mustard seed, agastache rugosa, radish seed, xylitol, donkey-hide gelatin, and tortoise-plastron gelatin. The Chinese herbal oral paste of the present disclosure has a higher drug concentration and good taste, is particularly suitable for health preserving in winter and conditioning the phlegm-dampness constitution, will not create negative effects or harm to the human body at all, and is capable of achieving certain efficacy of strengthening physical health. 1. A Chinese herbal oral paste for conditioning phlegm-dampness constitution , comprising the following raw material components in parts by weight: 10-30 parts of tangshen , 5-15 parts of prepared largehead atractylodes rhizome , 7-23 parts of prepared atractylodes rhizome , 5-15 parts of turmeric , 8-22 parts of unprocessed germinated barley , 3-9 parts of villous amomum fruit , 5-15 parts of coix seed , 5-15 parts of kelp , 4-17 parts of peach seed , 5-17 parts of tall gastrodia tuber , 6-18 parts of fuling , 5-15 parts of dried tangerine peel , 12-23 parts of seaweed , 5-15 parts of bitter apricot seed , 1-5 parts of cardamon fruit , 4-16 parts of perilla fruit , 5-15 parts of oriental waterplantain rhizome , 3-9 parts of ricepaperplant pith , 10-30 ...

Chinese Herbal Oral Paste for Keeping Balanced Constitution and Processing Method thereof

The present application discloses a Chinese herbal oral paste for keeping balanced constitution. The Chinese herbal oral paste includes the following raw material components: tangshen, largehead atractylodes rhizome, fuling, prepared liquorice root, glossy privet fruit, polygonatum odoratum, dwarf lilyturf tuber, flatstem milkvetch seed, Chinese yam, unprocessed hawthorn fruit, prepared fleeceflower root, milkvetch root, dried tangerine peel, angelica, dendrobium, Chinese arborvitae kernel, root and vine of manyprickle acanthopanax, radix asparagi, danshen root, figwort root, gorgon euryale seeds, villous amomum fruit, coix seed, mulberry fruit, fruit of Chinese magnoliavine, lilium brownii, prepared milkwort root, barbary wolfberry fruit, donkey-hide gelatin, tortoise-plastron gelatin, and xylitol. The Chinese herbal oral paste of the present disclosure has a higher drug concentration and good taste, is particularly suitable for health preserving in winter and conditioning the balanced constitution, will not create negative effects or harm to the human body at all, and is capable of achieving certain efficacy of strengthening physical health. 1. A Chinese herbal oral paste for keeping balanced constitution , comprising the following raw material components in parts by weight: 6-18 parts of tangshen , 5-15 parts of largehead atractylodes rhizome , 8-22 parts of fuling , 2-10 parts of prepared liquorice root , 7-23 parts of glossy privet fruit , 5-15 parts of polygonatum odoratum , 5-15 parts of dwarf lilyturf tuber , 5-15 parts of flatstem milkvetch seed , 6-18 parts of Chinese yam , 6-18 parts of unprocessed hawthorn fruit , 7-23 parts of prepared fleeceflower root , 5-15 parts of milkvetch root , 5-15 parts of dried tangerine peel , 5-15 parts of angelica , 8-22 parts of dendrobium , 6-14 parts of Chinese arborvitae kernel , 7-17 parts of root and vine of manyprickle acanthopanax , 5-16 parts of radix asparagi , 5-15 parts of danshen root , 6-14 parts of figwort ...

Chinese Herbal Oral Paste for Conditioning Blood Stasis Constitution and Processing Method therefor

The present application discloses a Chinese herbal oral paste for conditioning blood stasis constitution. The Chinese herbal oral paste includes the following components: unprocessed rehmannia root, peony root, angelica, sichuan lovage rhizome, motherwort herb, peach seed, safflower, licorice, orange fruit, platycodon root, twotoothed achyranthes root, rose flower, cortex moutan, kudzu vine root, nutgrass galingale rhizome, unprocessed cattail pollen, Chinese cinnamon, earthworm, suberect spatholobus stem, largeleaf gentian root, milkvetch root, snakegourd root, danshen root, sanqi powder, India madder root, unprocessed hawthorn fruit, donkey-hide gelatin, turtle shell gelatin, tortoise-plastron gelatin, xylitol, and stir-baked squama manitis. The Chinese herbal oral paste of the present disclosure has a higher drug concentration and good taste, is particularly suitable for health preserving in winter and conditioning the blood stasis constitution, will not create negative effects or harm to the human body at all, and is capable of achieving certain efficacy of strengthening physical health. 1. A Chinese herbal oral paste for conditioning blood stasis constitution , comprising the following components in parts by weight: 5-19 parts of unprocessed rehmannia root , 6-17 parts of peony root , 6-15 parts of angelica , 3-14 parts of sichuan lovage rhizome , 7-18 parts of motherwort herb , 6-15 parts of peach seed , 2-10 parts of safflower , 1-5 parts of licorice , 6-15 parts of orange fruit , 4-13 parts of platycodon root , 4-13 parts of twotoothed achyranthes root , 5-17 parts of rose flower , 3-14 parts of cortex moutan , 10-27 parts of kudzu vine root , 3-9 parts of nutgrass galingale rhizome , 5-16 parts of unprocessed cattail pollen , 1-5 parts of Chinese cinnamon , 6-17 parts of earthworm , 13-30 parts of suberect spatholobus stem , 6-14 parts of largeleaf gentian root , 8-17 parts of milkvetch root , 8-17 parts of snakegourd root , 7-17 parts of danshen root , 6- ...

HERBAL COMPOSITION FOR TREATING METASTATIC BREAST CANCER

The invention provides a composition comprising a mixture of extracts obtained from , and . The present invention further provides a method for treating metastatic breast cancer in a subject in need thereof, comprising: administering to said subject an pharmaceutically effective amount of the composition. 1Atractylodes macrocephala, Astragalus membranaceus, Taraxacum mongolicum, Poria cocos, Ligusticum chuanxiong, Ligustrum lucidum, Codonopsis pilosula, Glycyrrhiza uralensis, Hedyotis diffusa, Pseudostellaria heterophyllaViola philippica.. A composition comprising a mixture of extracts obtained from , and2. The composition of claim 1 , wherein the extracts are organic solvent extracts.3. The composition of claim 2 , wherein the organic solvent is selected from the group consisting of methanol claim 2 , ethanol claim 2 , acetic acid claim 2 , ketone claim 2 , hexane claim 2 , propanol claim 2 , isopropanol and chloroform.4. The composition of claim 1 , wherein the extracts are obtained from the whole plants.5. The composition of claim 1 , which has a concentration of ingredients as follows:{'i': Atractylodes macrocephala,', 'Astragalus membranaceus,', 'Taraxacum mongolicum,', 'Poria cocos,', 'Ligusticum chuanxiong,', 'Ligustrum lucidum,', 'Codonopsis pilosula,', 'Glycyrrhiza uralensis,', 'Hedyotis diffusa,', 'Pseudostellaria heterophylla', 'Viola philippica., '250 mg/mL of 330 mg/mL of 500 mg/mL of 330 mg/mL of 250 mg/mL of 250 mg/mL of 250 mg/mL of 160 mg/mL of 330 mg/mL of 250 mg/mL of , and 160 mg/mL of'}6Atractylodes macrocephala, Astragalus membranaceus, Taraxacum mongolicum, Poria cocos, Ligusticum chuanxiong, Ligustrum lucidum, Codonopsis pilosula, Glycyrrhiza uralensis, Hedyotis diffusa, Pseudostellaria heterophyllaViola philippica.. A method for treating metastatic breast cancer in a subject in need thereof claim 1 , comprising: administering to said subject an pharmaceutically effective amount of a composition comprising a mixture of extracts obtained from ...

Dietary supplement for promoting blood circulation and bones and muscles

A Bone-Strengthening Pill (BSP) as a dietary supplement to improve blood circulation and strengthen bone and muscle is characterized in that it is made from the following raw materials: -and L. BSP has the following beneficial effects: promoting blood circulation, dredging microcirculatory disturbance, significantly improving the level of human health, improving blood running in bone tissue and muscle tissue, and preventing or repairing microscopic damage of bone, cartilage tissue and muscle tissue. 1Angelica sinensis, Panax notoginsengCarthamus tinctorius. The Bone-Strengthening Pill (BSP) as a dietary supplement for improving blood circulation and strengthen bone and muscle , being characterized in that the BSP is made from following raw materials: and L.2Angelica sinensis:Panax notoginseng:Carthamus tinctorius. The BSP as a dietary supplement for improving the blood circulation and strengthen bone and muscle according to claim 1 , being characterized in the ratio of L. is 280-320:55-65:12-18 by weight.3. The BSP as a dietary supplement for improving the blood circulation and strengthen bone and muscle according to claim 1 , being characterized in the raw materials further include Lumbricus claim 1 , Pearl and Borneol.4. The BSP as a dietary supplement for improving the blood circulation and strengthen bone and muscle according to claim 3 , being characterized in the ratio of Lumbricus:Pearl:Borneol is 80-100:2-5:2-5 by weight.5Codonopsis pilosula, Rhizoma atractylodisPlatycodonopsis grandiflorum.. The BSP according as a dietary supplement for improving the blood circulation and strengthen bone and muscle according to claim 1 , being characterized in the raw materials further include and6Codonopsis pilosula:Rhizoma atractylodis:Platycodonopsis grandiflorum. The BSP as a dietary supplement for improving the blood circulation and strengthen bone and muscle according to claim 5 , being characterized in the ratio of 180-220:55-65:55-65 by weight.7Codonopsis pilosula, ...

SHENLINGBAIZHU GRANULES AND PREPARATION METHOD THEREOF

Disclosed are shenlingbaizhu granules and a preparation method thereof, wherein the shenlingbaizhu granules comprise an extract of raw material medicines and excipients, the raw material medicines being: 400 parts by weight of ginseng, 400 parts by weight of tuckahoe, 400 parts by weight of stir-fried with bran, 400 parts by weight of yam, 300 parts by weight of fried white hyacinth bean, 200 parts by weight of lotus seed, 200 parts by weight of coix seed stir-fried with bran, 200 parts by weight of , 200 parts by weight of , and 400 parts by weight of licorice, wherein the excipients comprise citric acid, stevioside and lactose, and the granules are dispersed by adding an appropriate amount of water and then obtaining a clear solution. 1Radix Ginseng,Poria,Rhizoma Atractyldis MacrocephalaeRhizoma Dioscoreae,Semen Dolichoris Album,Semen Nelumbinis,Semen CoicisFructus Amomi Villosi,Radix PlatycodonisRadix Glycyrrhizae. Shenlingbaizhu granules comprising an extract of raw material medicines and excipients , wherein the raw material medicines include 400 parts by weight of 400 parts by weight of 400 parts by weight of stir-baked in bran , 400 parts by weight of 300 parts by weight of stir-fried 200 parts by weight of 200 parts by weight of stir-baked in bran , 200 parts by weight of 200 parts by weight of and 400 parts by weight of , and the excipients include citric acid , stevioside and lactose; and wherein a clear solution can be obtained after dispersion by adding a proper amount of water into the shenlingbaizhu granules.2. The shenlingbaizhu granules according to claim 1 , wherein the shenlingbaizhu granules are administered to a 3-5 years old child in need 3 times a day with 1 g per time; and are administered to a 5-14 years old child in need 3 times a day with 2 g per time.3. A preparation method of shenlingbaizhu granules which raw material medicines include:{'i': Radix Ginseng,', 'Poria,', 'Rhizoma Atractyldis Macrocephalae', 'Rhizoma Dioscoreae,', 'Semen ...

COMPOSITIONS FOR ANTITUSSIVE, EXPECTORANT OR ANTI-INFLAMMATION

The present invention provides a composition containing, as active ingredients, , and Mel for an antitussive, expectorant, or anti-inflammatory action, and a composition for preventing, alleviating, or treating a respiratory disease. The present invention provides a compositions having excellent effects compared with an existing antitussive agent and expectorant agent. The compositions of the present invention are a naturally derived material and has little cytotoxicity, and thus is expected to be safely used as a medicine or food composition having antitussive, expectorant, and anti-inflammatory effects. 1Panax ginseng, Adenophora triphylla, Wolfiporia extensa, Rehmannia glutinosa. A composition comprising , and mel.2Panax ginseng,Adenophora triphylla,Wolfiporia extensa,Rehmannia glutinosa. The composition of claim 1 , wherein the composition comprises 4-5 wt % of 4-5 wt % of 8-10 wt % of 43-48 wt % of claim 1 , and 35-40 wt % of mel.3Panax ginseng, Adenophora triphylla, Wolfiporia extensa, Rehmannia glutinosa. A method for alleviating or treating cough claim 1 , sputum claim 1 , or an inflammatory disease claim 1 , the method comprising administering claim 1 , to a subject claim 1 , a composition comprising claim 1 , and mel.4Panax ginseng,Adenophora triphylla,Wolfiporia extensa,Rehmannia glutinosa. The method of claim 3 , wherein the composition comprises 4-5 wt % of 4-5 wt % of 8-10 wt % of 43-48 wt % of claim 3 , and 35-40 wt % of mel.5. The method of claim 3 , wherein the inflammatory disease is selected from the group consisting of dermatitis claim 3 , allergy claim 3 , edema claim 3 , atopic disease claim 3 , asthma claim 3 , conjunctivitis claim 3 , periodontitis claim 3 , rhinitis claim 3 , otitis media claim 3 , laryngopharingitis claim 3 , tonsillitis claim 3 , pneumonia claim 3 , stomach ulcer claim 3 , gastritis claim 3 , Crohn's disease claim 3 , colitis claim 3 , hemorrhoids claim 3 , vaginitis claim 3 , gout claim 3 , ankylosing spondylitis claim 3 ...

COMPOSITION FOR PREVENTING OR TREATING COLITIS

The present invention relates to a novel use of an Bunge extract and the like, and provides a composition for preventing or treating colitis, including an Bunge extract, a fraction thereof or a compound isolated therefrom as an active ingredient. In addition, the present invention relates to a novel use of a combined extract of medicinal herbs, and provides a composition for preventing or treating colitis, including an Bunge extract, a extract, a extract, and the like as active ingredients, or including an Bunge extract, a Makino extract, and the like as active ingredients. According to the present invention, the Bunge extract and the like or the combined extract can be used as a food or medical materials constituting a pharmaceutical composition or a nutraceutical composition. The pharmaceutical composition or the nutraceutical composition can be used for preventing or treating acute colitis or chronic colitis, and particularly, can effectively prevent, delay, alleviate or treat inflammatory bowel disease (IBD), irritable bowel syndrome (IBS), and the like. 1Anemarrhena asphodeloidesAnemarrhena asphodeloides. A composition for preventing or treating colitis , the composition comprising any one selected from an Bunge extract , a fraction , which is soluble in alcohol having 3 to 8 carbon atoms , of the Bunge extract , Mangiferin , Neomangiferin , or Timosaponin A-III , as an active ingredient.2Galla RhoisGalla Rhois. The composition of claim 1 , the composition further comprising any one selected from a extract claim 1 , a fraction claim 1 , which is soluble in alcohol having 3 to 8 carbon atoms claim 1 , of the extract claim 1 , or 1 claim 1 ,2 claim 1 ,3 claim 1 ,4 claim 1 ,6-penta-O-galloyl-β-D-glucose claim 1 , as an active ingredient.3Codonopsis lanceolataCodonopsis lanceolata. The composition of claim 1 , the composition further comprising any one selected from a extract claim 1 , a fraction claim 1 , which is soluble in alcohol having 3 to 8 carbon atoms ...

PHARMACEUTICAL COMPOSITION FOR TREATING INFERTILITY, AND PREPARATION METHOD AND USE THEREOF

The present invention provides a drug combination for the treatment of infertility and its crude drug comprises the medical ingredients with their weight proportions listed as below: 10-20 amounts by weight of Rehmannia, 10-20 amounts by weight of Chinese Peony, 10-20 amounts by weight of Asiatic Dogwood, 10-20 amounts by weight of Chinese Yam, 10-20 amounts by weight of Poria, 15-25 amounts by weight of Astragalus, 15-25 amounts by weight of Codonopsis, 10-20 amounts by weight of Epimedium and 10-20 amounts by weight of Jujube. The compatibility of this drug combination invented is precise, appropriate and possess outstanding curative effects. As shown in many experiments, the drug combination invented is safe and reliable, its toxic & side-effect is low and it has obvious improvement effects on female infertility caused by androgen, fallopian tube inflammation, tubal blockage and other factors. Furthermore, it can not only significantly improve the success rate of pregnancy, but also improve immunity and enhance the body's anti-fatigue and hypoxia tolerance. In short, the invention provides a safe and reliable new choice for clinical medication. 1. A composition to treat infertility in a subject in need of infertility treatment , said composition comprises the following crude drugs:10-20 amounts by weight of Rehmannia, 10-20 amounts by weight of Chinese Peony, 10-20 amounts by weight of Asiatic Dogwood, 10-20 amounts by weight of Chinese Yam, 10-20 amounts by weight of Poria, 15-25 amounts by weight of Astragalus, 15-25 amounts by weight of Codonopsis, 10-20 amounts by weight of Epimedium and 10-20 amounts by weight of Jujube.2. The composition as recited in claim 1 , wherein:the Rehmannia is 15 amounts by weight, the Chinese Peony is 15 amounts by weight, the Asiatic Dogwood is 15 amounts by weight, the Chinese Yam is 15 amounts by weight, the Poria is 15 amounts by weight, the Astragalus is 20 amounts by weight, the Codonopsis is 20 amounts by weight, the ...

HERBAL COMPOSITION AND METHOD OF USE

The present invention provides herbal compositions comprise Radix Dioscoreae, Radix Codonopsis, and Radix Astragalus Membranaceus. The herbal compositions are used to suppress intestinal glucose uptake of intestinal villus and decrease blood glucose levels. The present invention also provides methods of regulating blood glucose levels by administrating the herbal compositions. 1. An herbal composition for glycemic control , comprising Radix Dioscoreae , Radix Codonopsis , and Radix Astragalus Membranaceus.2. The herbal composition according to claim 1 , comprising 1-50 wt % of Radix Dioscoreae claim 1 , 1-50 wt % Radix Codonopsis claim 1 , and 1-50 wt % of Radix Astragalus Membranaceus.3. The herbal composition according to claim 2 , comprising 10 wt % of Radix Dioscoreae claim 2 , 10 wt % Radix Codonopsis claim 2 , and 10 wt % of Radix Astragalus Membranaceus.4. The herbal composition according to claim 1 , wherein the herbal composition further comprises pharmaceutically acceptable carrier.5. The herbal composition according to claim 1 , wherein the herbal composition is formulated to be administered orally.6. The herbal composition according to claim 5 , wherein the herbal composition is to suppress intestinal glucose uptake of intestinal villus.7. The herbal composition according to claim 1 , wherein herbal composition further comprises Herba Dendrobii claim 1 , Radix Ophiopogonis claim 1 , and Radix Puerariae.8. The herbal composition according to claim 7 , wherein herbal composition comprises 1-30 wt % of Radix Dioscoreae claim 7 , 1-30 wt % Radix Codonopsis claim 7 , 1-30 wt % of Radix Astragalus Membranaceus claim 7 , 1-10 wt % of Herba Dendrobii claim 7 , 1-30 wt % of Radix Ophiopogonis claim 7 , and less than 15 wt % of Radix Puerariae.9. The herbal composition according to claim 8 , wherein herbal composition comprises 10 wt % of Radix Dioscoreae claim 8 , 10 wt % Radix Codonopsis claim 8 , 10 wt % of Radix Astragalus Membranaceus claim 8 , 3 wt % of ...

Medicinal composition for prevention or treatment retinal ischemia

This invention relates to a method of preventing or treating a disease, disorder or condition induced by retina ischemia comprising administrating a subject a therapeutically effective amount of a RBP2 inhibitor for preventing or treating a disease, disorder or condition induced by retina ischemia. 1. A method of preventing or treating a disease , disorder or condition induced by retina ischemia comprising administrating a subject a therapeutically effective amount of a RBP2 inhibitor for preventing or treating a disease , disorder or condition induced by retina ischemia.2. The method according to claim 1 , wherein the RBP2 inhibitor is Xue-Fu-Zhu-Yu decoction. This application is a divisional of the pending U.S. patent application Ser. No. 15/490,863 filed on Apr. 18, 2017, all of which is hereby incorporated by reference in its entirety.This application contains a Sequence Listing in computer readable form. The computer readable form is incorporated herein by reference in its entirety.Although incorporated by reference in its entirety, no arguments or disclaimers made in the parent application apply to this divisional application. Any disclaimer that may have occurred during the prosecution of the above-referenced application(s) is hereby expressly rescinded. Consequently, the Patent Office is asked to review the new set of claims in view of the entire prior art of record and any search that the Office deems appropriate.This invention is related to a method of preventing or treating a disease, disorder or condition induced by retina ischemia comprising administrating a subject a therapeutically effective amount of a RBP2 inhibitor for preventing or treating a disease, disorder or condition induced by retina ischemia.Central retinal artery occlusion (CRAO), central retinal vein occlusion (CRVO), branch retinal artery occlusion (BRAO), branch retinal vein occlusion (BRVO), glaucoma, and age-related macular degeneration (AMD) are all associated with retinal ischemia. ...

METHOD FOR IMPROVING INTESTINAL HEALTH USING EXTRACTS OF CODONOPSIS LANCEOLATA

Disclosed is a method for improving intestinal microflora, which includes administering an extract of of an amount effective for improving intestinal microflora to a subject in need thereof. The extract can promote the proliferation of beneficial intestinal bacteria and suppress the proliferation of harmful bacteria. Also, the extract can improve intestinal health or intestinal function and improve defecation disorder. In addition, a synergic effect can be obtained when the composition of the present disclosure is used together with probiotics. 1Codonopsis lanceolata. A method for improving intestinal microflora , which comprises administering an extract of of an amount effective for improving intestinal microflora to a subject in need thereof.2Codonopsis lanceolata. The method for improving intestinal microflora according to claim 1 , wherein the extract of promotes the proliferation or growth of beneficial intestinal bacteria or suppresses the proliferation or growth of harmful intestinal bacteria.3Codonopsis lanceolata. The method for improving intestinal microflora according to claim 1 , wherein the extract of suppresses β-glucuronidase activity claim 1 , suppresses tryptophanase activity or increases intestinal short-chain fatty acids contents.4. The method for improving intestinal microflora according to claim 3 , wherein the short-chain fatty acid is one or more selected from a group consisting of acetate claim 3 , propionate claim 3 , isobutyrate claim 3 , butyrate claim 3 , isovalerate and valerate.5Codonopsis lanceolata. The method for improving intestinal microflora according to claim 1 , wherein the extract of improves defecation disorder.6Codonopsis lanceolata. The method for improving intestinal microflora according to claim 1 , wherein the extract of is administered together with probiotics.7Codonopsis lanceolata. The method for improving intestinal microflora according to claim 1 , wherein the extract of is administered in the form of a health food ...

PHARMACEUTICAL COMPOSITION COMPRISING AN EXTRACT OF PLATYCODON GRANDIFLORUM AND METHOD FOR PREVENTING OR TREATING OF OBESITY USING THE SAME

Provided is a composition for preventing, improving or treating obesity, which includes a extract as an active ingredient and a method for preparing the extract with an improved anti-obesity effect. The extract shows an effect of inhibiting increases in body weight and fat mass caused by a high-fat diet for normalization, an increase in fasting blood glucose and a decrease in energy expenditure in a diet-induced obesity mouse model. Further, compared to an extract prepared by a conventional extraction method, the extract shows a more excellent effect of inhibiting increases in body weight and fat mass, fasting blood glucose, and blood lipid and adipokine contents in experiments, resulting in an excellent anti-obesity effect. Therefore, the extract prepared is expected to be useful for preventing obesity and treating obesity-related complications that can be caused by an increase in fat mass as well as obesity. 1. A pharmaceutical composition for preventing or treating obesity , comprising:{'i': 'Platycodon grandiflorum', 'a extract as an active ingredient to normalize body weight and fat mass.'}2Platycodon grandiflorum. The pharmaceutical composition of claim 1 , wherein the extract is extracted with a solvent selected from the group consisting of water claim 1 , Cto Clower alcohols claim 1 , n-hexane claim 1 , ethylacetate claim 1 , acetone claim 1 , butylacetate claim 1 , 1 claim 1 ,3-butylene glycol claim 1 , methylene chloride claim 1 , and a mixture thereof.3Platycodon grandiflorum. The pharmaceutical composition of claim 1 , wherein the extract is extracted with an ethanol solvent.4. The pharmaceutical composition of claim 1 , wherein the composition inhibits increases in body weight and fat mass.5. The pharmaceutical composition of claim 1 , wherein the composition inhibits an increase in blood glucose.6. The pharmaceutical composition of claim 1 , wherein the composition inhibits a decrease in energy expenditure.7. The pharmaceutical composition of claim 1 , ...

HERBAL MEDICINAL TABLET FORMULATION FOR TREATING OBESITY WHICH CAN BE PRESCRIBED BASED ON SASANG CONSTITUTIONAL MEDICINE

An embodiment of the present invention provides an herbal medicinal tablet formulation for treating obesity which can be prescribed based on Sasang constitutional medicine, including: 2. The herbal medicinal tablet formulation for treating obesity which can be prescribed based on Sasang constitutional medicine of claim 1 , whereinthe side-effect preventing powder agent for each constitution includes alisma 1, platycodon 1, puerariae 1, acorus gramineus1, castanea mollissima 2, coicis semen 2, raphani semen 1, armeniacae amarum semen 1, cinnamon-vine 2, and nelumbinis semen 2 with respect to the ephedra powder agent 1 as a weight ratio in a case of Taeeumin.3. The herbal medicinal tablet formulation for treating obesity which can be prescribed based on Sasang constitutional medicine of claim 1 , whereinthe side-effect preventing powder agent for each constitution includes talcum 2, plaster 1, peppermint 1, gardeniae fructus 1, schizonepeta 1, rhubarb 1, natrii sulfas 1, rehmanniae radix cervi 2, and moutan 1 with respect to the ephedra powder agent 1 as a weight ratio in a case of Soyangin.4. The herbal medicinal tablet formulation for treating obesity which can be prescribed based on Sasang constitutional medicine of claim 1 , whereinthe side-effect preventing powder agent for each constitution includes ginseng radix 1, astragali radix 2, atractylodis macrocephalae rhioma 1, cinnamon 1, ginger 1, poria cocos 1, zizyphi fructus1, hawthorn 1, citrus unshiu markovich 1, and magnoliae cortex 1 with respect to the ephedra powder agent 1 as a weight ratio in a case of Soeumin.5. The herbal medicinal tablet formulation for treating obesity which can be prescribed based on Sasang constitutional medicine of claim 1 , whereinwhen an ephedrine content is constant at 3 to 4%, a weight of the ephedra powder agent is preferably about 360 g for Taeeumin, 297 g for Soeumin, and about 360 g for Soyangin.6. The herbal medicinal tablet formulation for treating obesity which can be ...

COMPOSITION FOR PREVENTING OR TREATING GLIOBLASTOMA COMPRISING PLATYCODON GRANDIFLORUM A. DE CANDOLLE, SCUTELLARIA BAICALENSIS, PHELLODENDRON AMURENSE RUPRECHT OR RUBUS COREANUS

The present invention relates to an extract of at least any one selected from the group consisting of Ruprecht, and or a fraction thereof; and to a use of the same for prevention, improvement, or treatment of glioblastoma multiforme. 1Platycodon grandiflorum, Scutellaria baicalensis, Phellodendron amurenseRubus coreanus,. A method for prevention or treatment of glioblastoma multiforme , which comprises administering a pharmaceutical composition for prevention or treatment of glioblastoma multiforme , comprising an extract of at least any one selected from the group consisting of Ruprecht , and or a fraction thereof as an active ingredient to a subject.2Platycodon grandiflorum, Scutellaria baicalensis, Phellodendron amurenseRubus coreanus,. The method of claim 1 , wherein the extract of at least any one selected from the group consisting of Ruprecht claim 1 , and or the fraction thereof is prepared by extracting with a solvent selected from the group consisting of water claim 1 , a Cto Calcohol claim 1 , and a mixed solvent thereof.3Platycodon grandiflorum, Scutellaria baicalensis, Phellodendron amurenseRubus coreanus. The method of claim 2 , wherein the extract of at least any one selected from the group consisting of Ruprecht claim 2 , and is prepared by hot water extraction.4Platycodon grandiflorum. The method of claim 1 , wherein the extract or a fraction thereof is contained in an amount of 0.01 wt % to 80 wt % relative to the total amount of the composition.5Platycodon grandiflorum. The method of claim 1 , wherein the extract or a fraction thereof comprises platycodin D.6. The method of claim 5 , wherein the platycodin D is contained in an amount of 0.01 wt % to 80 wt % relative to the total amount of the composition.7Scutellaria baicalensis, Phelloendron amurenseRubus coreanus,. The method of claim 1 , wherein the extract of at least any one selected from the group consisting of Ruprecht claim 1 , and or a fraction thereof inhibits autophagy is contained in ...

PHARMACEUTICAL COMPOSITION FOR DECREASING THE SIDE EFFECTS OF CANCER DRUG, AND MANUFACTURING METHOD AND USES THEREOF

The present invention provides a pharmaceutical composition comprising a mushroom, a rhizome, a fruit, a leaf, a flower, an alga, an energy-rich liquid, a salt-rich liquid, an assist agent and an anti-oxide agent. Said pharmaceutical composition has ability to protect liver, improve autoimmunity, reduce pain caused by cancer, protect an organ from the side-effects caused by chemical cancer drugs and increase the functions of chemical cancer drugs. 1. A pharmaceutical composition for decreasing the side effects of cancer drug , comprising: a mushroom , a rhizome , a fruit , a leaf , a flower , an alga , an energy-rich liquid , a salt-rich liquid , an assist agent and an anti-oxide agent.2Phellinus linteus,Ganoderma lucidum,Agaricus subrufescen,Antrodia cinnamomea,. The pharmaceutical composition of claim 1 , wherein the mushroom is selected from the group consisting of 24-36 grams of 16-24 grams of 16-24 grams of 4-6 grams of 4-6 grams of Caterpillar fungus and the combination thereof.3Rhizoma polygonati,Astragalus,Salvia miltiorrhiza,Codonopsis pilosula,Hedyotis diffusa,Eucommia ulmoides,Atractylodes macrocephala,Radix trichosanthis,Eleutherococcus senticosus,Ophiopogon japonicas,Rhodiola,. The pharmaceutical composition of claim 1 , wherein the rhizome is selected from the group consisting of 16-24 grams of 8-12 grams of 8-12 grams of 8-12 grams of 12-18 grams of 12-18 grams of 8-12 grams of 8-12 grams of 8-12 grams of 8-12 grams of 8-12 grams of 2.4-3.6 grams of Peeled Licorice and the combination thereof.4Ligustrum lucidum,Schisandra chinensis,Siraitia grosvenorii,. The pharmaceutical composition of claim 1 , wherein the fruit is selected from the group consisting of 12-18 grams of Job's Tears claim 1 , 8-12 grams of 8-12 grams of 9.6-14.4 grams of Germinated brown rice claim 1 , 8-12 grams of lotus seed claim 1 , 8-12 grams of Black sesame claim 1 , 8-12 grams of Corn Silk claim 1 , 8-12 grams of 1.6-2.4 grams of powder extract from red grape skin and the ...

Composition for preventing or treating colitis

The present invention relates to a novel use of an Anemarrhena asphodeloides Bunge extract and the like, and provides a composition for preventing or treating colitis, including an Anemarrhena asphodeloides Bunge extract, a fraction thereof or a compound isolated therefrom as an active ingredient. In addition, the present invention relates to a novel use of a combined extract of medicinal herbs, and provides a composition for preventing or treating colitis, including an Anemarrhena asphodeloides Bunge extract, a Galla Rhois extract, a Codonopsis lancellata extract, and the like as active ingredients, or including an Anemarrhena asphodeloides Bunge extract, a Coptis japonica Makino extract, and the like as active ingredients. According to the present invention, the Anemarrhena asphodeloides Bunge extract and the like or the combined extract can be used as a food or medical materials constituting a pharmaceutical composition or a nutraceutical composition. The pharmaceutical composition or the nutraceutical composition can be used for preventing or treating acute colitis or chronic colitis, and particularly, can effectively prevent, delay, alleviate or treat inflammatory bowel disease (IBD), irritable bowel syndrome (IBS), and the like.

Traditional chinese medicine combination for regulating immune function and preparation method therefor

The present invention relates to a traditional Chinese medicine composition for regulating immunity and preparation method thereof, characterized in that the composition comprises raw materials such as Radix Panacis Quinquefolii, Ganoderma , fermented Cordyceps sinensis powder, Flos Rosae Rugosae, and Rhizoma Anemarrhenae and is prepared into various conventional pharmaceutical formulations through processes such as pulverization, water decoction and alcohol extraction. The traditional Chinese medicine composition is effective in preventing and treating allergic diseases, hepatitis B and AIDS, elevating leukocytes, preventing and treating radiation injury, reducing toxic and side effects resulting from radiotherapy and chemotherapy, improving the male sexual function, enhancing immunity of the human body and alleviating physical fatigue.

COMPOSITION FOR PREVENTING OR TREATING CANCER

The present invention provides a pharmaceutical composition for preventing or treating cancer, a food composition for enhancing immune functions, and a pharmaceutical composition for preventing or treating cachexia. The composition of the present invention provides effects of further inhibiting the growth of tumors, increasing immunological activity, and suppressing cachexia caused by tumors. In addition, the composition of the present invention can obtain a synergistic effect when co-administered with an existing anticancer drug. 1. A method for treatment of cancer comprising a step:{'i': 'Panax ginseng, Adenophorae triphylla, Wolfiporia extensa, Rehmannia glutinosa', 'administering, to a subject, a composition comprising , and mel.'}2Panax ginseng,Adenophorae triphylla,Wolfiporia extensa,Rehmannia glutinosa. The method of claim 1 , wherein the composition comprises 4-5 wt % of 4-5 wt % of 8-10 wt % of 43-48 wt % of claim 1 , and 35-40 wt % of mel.3Panax ginsengAdenophorae triphyllaWolfiporia extensaRehmannia glutinosa. The method of claim 1 , wherein the composition comprises 4-5 wt % of dried powder claim 1 , 4-5 wt % of dried powder claim 1 , 8-10 wt % of dried powder claim 1 , 43-48 wt % of juice extract claim 1 , and 35-40 wt % of mel.4. The method of claim 1 , wherein the composition further comprises gefitinib.5. The method of claim 1 , wherein the method further comprises a step administering gefitinib to the subject.6. The method of claim 5 , wherein gefitinib is administered within 5 minutes before or after administering the composition.7. A method for enhancement of immune functions comprising a step:{'i': 'Panax ginseng, Adenophorae triphylla, Wolfiporia extensa, Rehmannia glutinosa', 'administering, to a subject, a composition comprising , and mel.'}8. The method of claim 7 , wherein the composition further comprises gefitinib.9. The method of claim 7 , wherein the subject is a cancer patient.10. The method of claim 7 , wherein the method is for ...

COMPOSITION FOR PREVENTING OR ALLEVIATING HANGOVER, CONTAINING LONGAN ARILLUS EXTRACT

Provided are a pharmaceutical composition for preventing an alcoholic hangover or alleviating a hangover, comprising a extract as an active ingredient, and a food composition for alleviating a hangover, comprising a extract. 1Longan arillus. A pharmaceutical composition for activating alcohol metabolism in liver tissue , or preventing or reducing an alcoholic hangover , comprising a extract as an effective ingredient.2Angelicae tenuissimaePolygalae. The pharmaceutical composition of claim 1 , further comprising an extract from at least one selected from the group consisting of Radix and Radix.3Longan arillus, PolygalaeAngelicae tenuissimae. The pharmaceutical composition of claim 2 , wherein the extract is a combined extract from a mixture of Radix claim 2 , and Radix at a weight ratio of 1:0.1 to 10:0.1 to 10.4PuerariaeScutellariaePlatycodonisAngelica dahurica, CimicifugaeRaphaniAcori Gramineri. The pharmaceutical composition of claim 1 , further comprising an extract from at least one selected from the group consisting of Radix claim 1 , Radix claim 1 , Radix claim 1 , rhizoma claim 1 , semen claim 1 , and rhizoma.5. The pharmaceutical composition of claim 1 , wherein the extract is obtained using water claim 1 , at least one organic solvent selected from the group consisting of linear or branched lower alcohols of Cto C claim 1 , or a mixture of water and the at least one organic solvent.6. The pharmaceutical composition of claim 5 , wherein the extract is obtained using water claim 5 , ethanol claim 5 , or a mixture of water and ethanol.7Longan arillus. A food composition for activating alcohol metabolism in liver tissue claim 5 , or preventing or reducing an alcoholic hangover claim 5 , comprising a extract as an effective ingredient.8Angelicae tenuissimaePolygalae. The food composition of claim 7 , further comprising an extract from at least one selected from the group consisting of Radix and Radix.9Longan arillus, PolygalaeAngelicae tenuissimae. The food ...

Crude Drug Composition For Preventing Or Treating Respiratory Diseases

The present disclosure relates to a pharmaceutical composition for preventing or treating respiratory diseases and a food composition for preventing or relieving respiratory diseases comprising as an active ingredient two or more mixed extracts selected from the group consisting of a Brassicae Semen extract, an Adenophorae Radix extract, a Lonicerae Folium extract and a Perillae Semen extract. A composition comprising mixed extracts of Brassicae Semen, Adenophorae Radix, Lonicerae Folium and Perillae Semen of the present disclosure has an advantage of preventing respiratory diseases and relieving the symptoms of respiratory diseases, restores damages in the lung tissue, inhibits aging action and inflammation induced by inflammation-inducing substances such as fine dust, and has an excellent antioxidant effect. More particularly, the composition of the present disclosure increases the expression of a telomerase which extends the length of a telomere. 1. A composition comprising a mixed extract of two or more selected from the group consisting of a Brassicae Semen extract , an Adenophorae Radix extract , a Lonicerae Folium extract , and a Perillae Semen extract.2. The composition of claim 1 , wherein the extracts are obtained by extraction with an organic solvent claim 1 , water claim 1 , or a mixed solvent thereof.3. The composition of claim 2 , wherein the organic solvent is selected from the group consisting of a C1 to C6 lower alcohol claim 2 , petroleum ether claim 2 , hexane claim 2 , benzene claim 2 , chloroform claim 2 , methylene chloride claim 2 , ether claim 2 , ethyl acetate claim 2 , and acetone.4. The composition of claim 1 , wherein the respiratory disease is selected from the group consisting of a cold claim 1 , rhinitis claim 1 , pharyngitis claim 1 , laryngitis claim 1 , pharyngolaryngitis claim 1 , pneumonia claim 1 , acute or chronic bronchitis claim 1 , asthma claim 1 , and chronic obstructive pulmonary disease.56-. (canceled)7. A Method for ...

一种含有桔梗提取物的用于预防和治疗肌肉疾病或改善肌肉功能的组合物

本发明涉及一种用于预防和治疗肌肉疾病或改善肌肉功能的组合物，其含有桔梗提取物。更具体而言，本发明涉及一种用于预防和治疗肌肉疾病的药物组合物，其含有桔梗提取物；一种用于预防肌肉疾病或改善肌肉功能的食品组合物；或一种用于改善肌肉功能的化妆品。本发明的桔梗提取物通过诱导肌肉蛋白质合成和肌肉细胞分化来增加肌肉形成。因此，提取物是天然产物，以便安全使用而没有副作用，从而可用作药物，食品，化妆品组合物的活性成分，其在预防和治疗肌肉疾病或改善肌肉功能上具有突出的效果。

治疗肝纤维化和肝硬化的中药组合物及其制备方法

本发明涉及一种治疗肝纤维化和肝硬化的中药组合物及其制备方法，其中治疗肝纤维化和肝硬化的中药组合物，包括如下重量份的原料制备而成：三七5‑15份、醋鳖甲10‑30份、醋龟甲10‑30份、黄芪10‑30份、白术10‑30份、茯苓10‑30份、郁金10‑30份、桃仁10‑30份、枳壳10‑30份、五味子10‑30份、半边莲15‑45份、丹参20‑60份和叶下珠20‑60份。本发明的治疗肝纤维化和肝硬化的中药组合物具有活性强、作用持久且低毒的优点。

一种治疗梅尼埃病的药物及其制备方法

本发明公开了一种治疗梅尼埃病的药物及其制备方法，其主要是由龙骨、泽泻、瞿麦、茯苓、牡蛎、地龙、黄芪、葛根、猪苓、珍珠母、薏苡仁、丹参、白术、赭石、山药、磁石、川芎、酸枣仁、刺蒺藜、党参、牛膝按一定重量配比制备而成，本发明药物具有敛汗固精、泄热、益脾和胃、宁心安神、行气开郁、燥湿化痰的功能，用于治疗梅尼埃病见效快、疗效好，不复发。

一种预防和治疗慢性肾炎的中药组合物

本发明涉及一种预防和治疗慢性肾炎的中药组合物，由下列重量份的原料药制成：白茅根15-35份，茯苓10-30份，三七10-25份，香附10-25份，肾茶10-30份，桃仁10-25份，贯叶金丝桃5-20份，泽泻5-25份，熟地10-20份，女贞子10-35份，侧柏叶5-25份，党参5-20份。该中药组合物具有利水行气、活血化瘀、清热解毒、祛风除湿的功效，用于预防和治疗慢性肾炎，无毒副作用，效果显著。

一种治疗乳腺炎的药物及其制备方法

本发明为一种治疗乳腺炎的药物，其主要以苍耳子、冰片、黄连、党参、麻黄、杜仲、田七和甘草等中草药为原料，通过文火反复煎熬，将药液浓缩成稠膏状，然后将所得的稠膏状药物加入常规辅料，再烘干、研碎、制成散剂，包装后得成品。本发明药物清热解毒、消滞通络，可以治疗各种类型乳腺炎。

Composition containing water-containing organic solvent extract for food, composition containing water-containing organic solvent extract for medicine, and methods for producing them

물함유 유기용매에 의하여 얻은 추출물을 함유하는 조성물 및 그 제조방법

내용 없음

Pharmaceutical composition for preventing or treating atopic dermatitis containing the membrane-separated extracts of platycodon grandiflorum or platycoside E as an active ingredient

본 발명은 도라지 막분리 추출물 또는 플라티코시드 Ｅ를 유효성분으로 함유하는 아토피 피부염의 예방 또는 치료용 약학적 조성물에 관한 것으로, 본 발명에 따른 도라지 막분리 추출물 또는 플라티코시드 E는 아토피 증상을 완화시킬 뿐만 아니라, 염증세포 침윤, 괴사 딱지의 발생, 조직의 두께 및 비만세포 수를 감소시키고, 혈중 IgE 함량 및 IL-4 함량을 용량의존적으로 감소시킴으로써 아토피 피부염을 예방 또는 치료하는데 유용하게 사용할 수 있다. The present invention relates to a pharmaceutical composition for the prevention or treatment of atopic dermatitis, which contains bellflower membrane extract or Platicoside E as an active ingredient. The bellflower membrane extract or Platicoside E according to the present invention alleviates atopic symptoms. In addition, it can be usefully used to prevent or treat atopic dermatitis by reducing inflammatory cell infiltration, occurrence of necrotic scab, tissue thickness and mast cell number, and dose-dependently reducing blood IgE content and IL-4 content. .

Plant extract from Adenophora remotiflora and composition containing the same with hypoglycemic activity

본 발명은 모시대 추출물과 그를 함유한 혈당강하용 조성물에 관한 것으로, 모시대의 잎, 뿌리, 줄기 등으로부터 물 또는 유기용매로 추출한 모시대 추출물은 알파글루코시다제 및 알파아밀라제 효소활성을 억제하여 식후 혈중 포도당 농도의 급격한 상승을 억제하여 인체나 동물의 당뇨병 예방 및/또는 치료에 이용할 수 있는 매우 뛰어난 효과가 있다. The present invention relates to a seedling extract and a composition for lowering blood sugar containing the same, wherein the seedling extract extracted from water, organic solvent or the like from the leaves, roots, and stems of the seedlings inhibits the enzyme activity of alphaglucosidase and alphaamylase to suppress the enzyme activity of blood glucose after meals. There is a very excellent effect that can be used to prevent and / or treat diabetes in humans or animals by suppressing rapid rise in concentration.

一种铜锤玉带草提取物及其制备方法和应用

本发明特别涉及一种铜锤玉带草提取物及其制备方法和应用，属于药物制备技术领域，应用包括将所述铜锤玉带草提取物用于治疗乳腺癌；扩大了铜锤玉带草的药用范围，提高了铜锤玉带草的药用价值，另外，具有治疗乳腺癌作用的铜锤玉带草提取物的制备方法简单易操作，为铜锤玉带草提取物在治疗乳腺癌的药物和制备辅助治疗乳腺癌的功能性食品的应用上奠定了基础。

一种治疗颈源性头痛的中药

本发明涉及中药技术领域，特别涉及一种治疗颈源性头痛的中药。该治疗颈源性头痛的中药，其特殊之处在于：主要由以下重量份数的原料制成：党参2-5份，木香2-6份，灵芝1-4份，香附1-5份，黄芪2-5份，桂枝1-4份，赤芍2-4份，豨莶2-4份，麻黄1-3份，川芎2-6份，黄精1-3份，甘草2-6份，地龙1-4份，牛蒡子2-5份，柏子仁2-6份，麦冬1-3份，刺五加2.5-5份，知母1-4份，鸡血藤1-4份，佩兰1-4份，大腹皮2-4份，白花蛇舌草1-2份，苍耳1-3份，回心草2-5份，红花2-4份。本发明吸收效果好、疗效显著、无副作用，能减少病人痛苦，提高了病人的生活质量；而且其无毒副作用，病人可安心服用，总有效率达96％。

一种治疗带状疱疹的中药组合物

本发明公开了一种治疗带状疱疹的中药组合物，该中药组合物的原料组成为：石膏25-35份、蒲公英25-35份、连翘25-35份、黄芩10-15份、漏芦10-15份、荆芥5-10份、防风5-10份、白芷5-10份、羌活5-10份、海金沙10-15份、滑石13-18份、千里光18-23份、蝉蜕5-10份、浮萍10g、柴胡5-10份、白芍10-15份、牡丹皮5-10份、皂角刺5-10份、鸡内金10-15份、桔梗5-10份。本发明组合物治疗带状疱疹既可内服又能外用，具有起效快、疗效好、治愈率高的特点。

Treat the Chinese medicine of breast cancer

本发明公开了一种治疗乳腺癌的中药，涉及药品领域，该乳癌肿瘤内外消采用全当归、金银花、天花粉、八仙草、生白芍、瓜蒌、生甘草、生赤芍、王不留行、四叶草、青皮、关木通、银柴胡、生北黄芪、甜桔梗、皂角刺、关防风、香附、败酱草、北蒲公英全草、夏枯草、广陈皮、丹参、七叶一枝花、白芨、天葵子、明党参、鹿角胶、白毛藤全草、土炒白术、血竭、黄柏、黄药子、山慈姑、猫爪草、穿山甲、北黄芩为原料制造，毒素小，对身体伤害少，治疗效果好，副作用小。

一种用于保护胃粘膜的组合物及其制剂和制备方法

本发明属于医药领域，提供一种对胃粘膜有辅助保护功能的组合物，包括按质量份计的以下成分：党参1～12份、茯苓1～12份、白术1～12份、甘草0.5～4份和白及0.5～4份。本发明的组合物中，甘草酸、总黄酮和粗多糖的含量丰富，有益于胃粘膜的修护。

Traditional Chinese medicine composition for improving kidney qi deficiency of middle-aged and old people and application thereof

本发明涉及一种改善中老年肾气虚证的中药组合物及其应用。所述中药组合物由下述重量份的原料药制成：党参15‑25份、炙黄芪15‑25份、当归12‑18份、补骨脂15‑25份、鹿含草15‑25份、枸杞子10‑20份、赤芍10‑20份。临床试验表明该中药组合物可显著改善中老年肾气虚证患者的症状及生活质量，因此可用于制备治疗肾气虚证及延缓衰老的药物，此外该中药组合物还具备药味组成少、便于制备、成本低的优点。

Oriental medicine extract for prevention of alopecia and hair article composition

본 발명은 헤어용품 본연의 기능을 감소시키지 않으면서 탈모를 방지하고 두피를 보호함과 동시에 두피의 혈액순환을 자극하여 발모를 촉진시키며 항균 및 항산화효과까지 제공될 수 있도록 한 탈모방지용 한방추출물 및 이를 포함하는 헤어용품 조성물에 관한 것이다. 본 발명에 따른 탈모방지용 한방추출물은, 황련, 황백, 황금, 황정, 황기, 백지, 야국화, 감초, 및 생강이 혼합추출되어 제조되거나, 또는 고과, 발아 서목태, 측백엽, 당삼, 당귀, 블루베리, 상백피, 한련초, 옥잠화, 지황, 홍삼, 하수오, 목단피, 형개, 우방자 및 방풍이 혼합추출되어 제조된다. 또한 본 발명에 따른 헤어용품 조성물은 헤어샴푸원재, 헤어컨디셔너원재 또는 헤어에센스원재로 이루어지는 헤어용품원재와, 황련, 황백, 황금, 황정, 황기, 백지, 야국화, 감초, 및 생강이 혼합추출되어 제조되는 제 1 탈모방지용 한방추출물과, 고과, 발아 서목태, 측백엽, 당삼, 당귀, 블루베리, 상백피, 한련초, 옥잠화, 지황, 홍삼, 하수오, 목단피, 형개, 우방자 및 방풍이 혼합추출되어 제조되는 제 2 탈모방지용 한방추출물을 포함하여 이루어지고, 상기 제 1 탈모방지용 한방추출물과 상기 제 2 탈모방지용 한방추출물은 4 : 6 내지 6 : 4의 중량비로 혼합된 후 5 내지 35중량부로 상기 헤어용품원재 57 내지 93 중량부에 첨가된다. The present invention prevents hair loss and protects the scalp without reducing the natural function of hair products, while stimulating the blood circulation of the scalp to promote hair growth and to provide antibacterial and antioxidant effects, and herbal extracts for preventing hair loss It relates to a hair care composition comprising. Herbal extracts for preventing hair loss according to the present invention is prepared by mixing a mixture of yellow lotus, yellow white, golden, yellow, yellow, white paper, chrysanthemum, licorice, and ginger, or fruit, germinated Seokmoktae, baekyebyeon, Dangsam, Angelica, Blueberry , Baekbaekpi, nasturtium, daylily, jihwang, red ginseng, sewage, mokdanpi, hyeonggae, allies and windproof is produced by mixing. In addition, the hair care composition according to the present invention is a hair shampoo raw material, hair conditioner raw material or hair essence raw material consisting of raw material, yellow lotus, yellow white, golden, yellow, yellow, white paper, chrysanthemum, licorice, and ginger are mixed and extracted The first herbal extract for hair loss prevention, medicinal fruit, germinated Seomoktae, baekyebyeon, Dangsam, Angelica, Blueberry, Sangbaekpi, Nasturtium, Daylily, Chihwang, Red Ginseng, Sewage, Barley Peel, Hungae, allies and windproof 2 ...

Traditional Chinese medicine preparation capable of treating chronic gastritis

本发明公开了一种治疗慢性胃炎的中药制剂，由以下重量的中药原料制成：法半夏8-12克，佛手6-15克，黄连2-10克，枳实10-20克，党参10-20克，白术10-20克，刺猬皮10-20克，生牡蛎10-20克，枸橘10-20克，穿山甲2-8克，半枝莲20-40克，炙甘草2-8克。本发明组方合理，服用方便，无毒副作用，可有效治疗慢性胃炎，健脾益气，消除患者病痛。

Decoction capable of effectively treating anemia and preparation method thereof

本发明属于中医药技术领域，目的是根据中医对贫血的认识机理而提供的一种可有效治疗贫血的汤剂药物，所述药物的各个组分及其质量份比如下所示：当归5～15g、肉桂2～8g、熟地10～30g、鸡内金5～15g、麦芽3～15g、决明子9～15g、金樱子7.5～15g、黄芪10～22g、党参6～15g、大蒜7.5～15g、白芍10～20g、人参3～15g、山萸肉5～10g、大黄3～12g、羌活3～10g、鹿角胶3～9g、龙眼肉10～15g、鸡血藤15～25g、牛膝15～25g、黄精15～25g、沙苑子10～15g、红景天3～8g、甘草2.5～15g、阿胶3～9g、女贞子7～16g；本发明药物是一个标本兼治的中药配方。

Anti-tumor comprehensive conditioning cream and preparing technology thereof

一种具有抗肿瘤综合调养膏方，涉及中草药技术领域，其特征在于，由以下重量的组份组成：黄芪80-160g、党参80-160、黄精80-160g、苍术80-120g、枸杞子80-120g、茯苓80-160g、猪苓80-160g、薏苡仁80-160g、山药120-160g、女贞子80-120g、三七30-80g、首乌20-110g、白芍80-120g、山楂80-120g、蜂蜜300-500g、阿胶300-500g、黄酒300-500g、红枣120-160g、灵芝孢子粉10-60g、松花粉30-60g、白参菌60-110g。本发明在中医指导下整体观念强，针对性强，以调节免疫、扶正祛邪、强身为目的，尤其是以膏剂为主对肿瘤患者具有综合调养的养生产品，该产品的开发与应用不仅填补国内空白，而且造福人类，为人类健康事业作出贡献，具有良好的经济效益和社会效益，有极大的开展前景。

The External-applicationtraditional traditional Chinese medicinal prevented and treated for teenager's eyesight improving and senile eye illness

用于青少年视力改善及老年性眼疾防治的外敷中药组合物，使用的中药组方包括党参、白术、川芎、当归、酸枣仁、远志、五味子、茯神、枸杞子、山茱萸、石菖蒲、蔓荆子、灸甘草、珍珠粉、决明子、芦荟、野菊花、冰片，使用的西药组方包括叶黄素酯、维生素E乳液，通过四个步骤将西药组方和中药组方制得外敷中药组合物成品，步骤A：制备挥发油包合物；步骤B:滤液制备；步骤C：干膏制备；步骤D:将步骤A、C中所得挥发油包合物、粉碎后干膏，加入叶黄素酯、维生素E乳液、乳糖及乙醇。本发明各种药物的有效成分直接作用于眼部，深入患处肌肤内、调节患处血液循环、促进新陈代谢、排出毒素，从根源上治疗各种青少年视力问题及老年人眼部黄斑变性。

Toxin-removing oral liquid containing fineleaf schizonepeta herbs and divaricate saposhnikovia roots and preparation method of oral liquid

本发明属于中药技术领域，具体涉及一种荆防败毒口服液，其原料包括以下重量份的组分：荆芥8～12份、防风8～12份、羌活6～10份、独活6～10份、党参5～8份、白术5～8份、黄芪5～8份、当归5～8份、川芎4～6份、枳壳3～5份、柴胡4～6份、升麻4～6份、茯苓4～6份、陈皮3～5份、前胡3～5份、桔梗3～5份、甘草3～5份，并根据方中各药物有效成分的性质特点，以化学成分和药理效应为指标，制定合理的制备路线。本发明荆防败毒口服液能在提高免疫力的基础上祛邪，以达到标本兼治的目的。

Composition for preventing, ameliorating or treating type 2 diabetes mellitus or dyslipidemia comprising bangpungtongseongsan extract as effective component

본 발명은 방풍통성산 추출물을 유효성분으로 포함하는 제2형 당뇨 및 이상지질혈증의 예방, 개선 또는 치료용 조성물에 관한 것이다. 보다 상세하게는, 감초, 석고, 황금, 길경, 방풍, 작약, 천궁, 당귀, 대황, 마황, 박하, 연교, 망초, 형개, 백출, 치자 및 활석으로 이루어진 방풍통성산 추출물을 유효성분으로 포함하는 제2형 당뇨 및 이상지질혈증의 예방 또는 치료용 약학적 조성물, 및 제2형 당뇨 및 이상지질혈증의 예방 또는 개선용 식품 조성물에 관한 것이다. 본 발명의 방풍통성산 추출물, 보다 상세하게는 감초, 석고, 황금, 길경, 방풍, 작약, 천궁, 당귀, 대황, 마황, 박하, 연교, 망초, 형개, 백출, 치자 및 활석으로 이루어진 방풍통성산 물 추출물을 유효성분으로 포함하는 조성물은 제2형 당뇨 동물 모델에 적용시 혈당, 당화혈색소 및 저밀도지단백(LDL-C) 수치를 감소시키고, 간의 지방 축적을 저해시키므로, 제2형 당뇨 및 이상지질혈증의 예방, 개선 또는 치료를 위한 의약품 및 식품 등에 유용하게 이용될 수 있다.

Composition comprising the extract of old platycodon or the purified extract therefrom for preventing and treating allergy

본 발명은 장생도라지 조추출물 또는 이로부터 분리된 정제 분획물을 유효성분으로 함유하는 알러지 질환의 예방 및 치료용 조성물에 관한 것으로서, 상세하게는 본 발명의 장생도라지 조추출물 또는 이로부터 분리된 정제 분획물은 과도한 면역반응인 수동 피부 아나필락시스 반응 (passive cutaneous anaphylaxis reaction)억제효과, 비만세포주로부터 베타-헥소사미니데이즈 (β-hexosaminidase) 및 히스타민 (histamine)의 방출 억제량 효과 및 알러지 유발인자인 IL-4 (interleukin-4) 및 IgE (Immunoglobulin E)의 생성량억제효과를 나타내므로, 알러지 질환의 예방 및 치료용 약학조성물 및 건강기능식품으로 유용하게 이용될 수 있다. The present invention relates to a composition for the prevention and treatment of allergic diseases containing Jangsaeng Bellflower crude extract or purified fractions separated therefrom as an active ingredient, in detail, Jangsaeng Bellflower crude extracts or purified fractions separated therefrom Inhibition of passive cutaneous anaphylaxis reaction, which is an excessive immune response, inhibitory effect of beta-hexosaminidase and histamine release from mast cell lines, and allergen trigger IL-4 ( Since the production of interleukin-4) and IgE (Immunoglobulin E) inhibitory effect, it can be useful as a pharmaceutical composition and health functional food for the prevention and treatment of allergic diseases. 장생도라지 조추출물, 장생도라지 정제 분획물, 알러지 질환, IgE, IL-4 Crude Extract of Jangsaeng Bellflower, Purified Fraction of Jangsaeng Bellflower, Allergic Disease, IgE, IL-4

Chinese herbal mouthwash for treating fungal infection of oral cavity

本发明提供了一种用于防治口腔真菌感染的中药漱口液，其原料包括用于防治口腔真菌感染的中药复方提取成分、山梨酸钾、维生素C、蔗糖、柠檬酸硬脂酰单甘油酯、羧甲基纤维素钠、十八醇聚氧乙烯醚、十二烷基磺酸钠、乙醇和水。该药不仅可以有效的杀灭白色念珠菌，并且有助于恢复口腔其他菌群平衡，此外，抗真菌药物毒性和耐药性较大，而该药根据患者的体质进行用药，可以扶助正气，抗邪外出，迅速治疗口腔真菌感染，本发明制剂一个特色是采用中药漱口液的剂型，可以局灶用药，迅速起效，避免了内服用药后将真菌由消化道进入体内，引起其他感染，具有十分好的应用前景。

The method that extract aromatic substance from chinese herb medicine

PURPOSE: A method for extracting aromatic substances from chinese herb medicine is provided to reduce extraction time while simplifying a process compared with an existing refined oil extraction method. CONSTITUTION: A method for extracting aromatic substances from chinese herb medicine comprises the steps of: (S100) drying, mixing, and pulverizing glycyrrhizae radix, Platicodi Radix, rhei Rhizoma, menthae Herba, atractylodis Rhizoma alba, cnidii Rhizoma and Nepetae Spica; (S200) putting the pulverized mixture in a supercritical extraction tub and supplying the supercritical fluid; (S300) maintaining the supercritical extraction tub with 200~500 of inner pressure and 65 °C temperature for constant hour; (S400) reducing the inner pressure of the supercritical extraction tub and extracting the extract from the mixture; and (S500) removing wax components and nonvolatile materials by dissolving them by a solvent.

Granules being rich in selenium and germanium and having efficacies of building body and prolonging life

本发明公开了一种富硒锗强体益寿颗粒冲剂，是属于古为今用元素药石颗粒冲剂配制生产技术领域。由富硒锗补益心肾活血化瘀，清热解毒活血通络。益气养心化痰通络，滋肾强精温肾助阳，补益心肾阴阳两虚，滋肾养心活血祛风防衰抗老，健脾开胃益气生血强体益寿颗粒冲剂组成。方剂中含有人体的多种必需的微量元素，其中以Fe，Zn，Mn，Cu含量较高。并强化添加硒锗元素，中药以传统精典方为依据，辅以具有独特复杂多孔穴能溶出多种元素，吸附过敏源，重金属和毒素的矿石纳米粉，诸药协同共用达到增强免疫，促进血液循环，补益心、肝、脾、肺、肾、防癌、益寿。

A kind of Chinese medicine treating yin asthenia generating intrinsic heat pattern of syndrome hydrothorax disease

本发明公开了一种治疗阴虚内热证型悬饮病的中药，其特征是由下列重量配比的药材制成的中药制剂：麦冬38—40份，桑白皮20—22份，鳖甲8—12份，郁金15—20份，天花粉28—30份，白芍18—20份，玉竹25—30份，沙参22—25份，生地黄20—22份，百合23—25份，熟地黄18—20份，甘草18—20份。本发明将以上各种原料有机地组合在一起，各成份之间相互协调，相互作用，对阴虚内热证型悬饮病能够标本兼治，且对身体有良好的调理作用。多年来，通过对50例此类患者的跟踪调查统计，表明此药方有效率达到100%，显效率达到100%，治愈率达到88%。

Pharmaceutical preparation for treating pancreatic cancer and application thereof

本发明提供一种治疗胰腺癌的药物制剂及其用途，按照重量分数比其成分包括：党参8‑15份，夏枯草10‑20份，炒白术5‑15份，白花蛇舌草10‑20份，八月札20‑30份，茯苓10‑20份，茯神10‑20份，山慈姑10‑20份，炒麦芽15‑30份，半枝莲10‑15份，山药10‑20份，全瓜蒌5‑15份，大腹皮10‑20份，猪苓20‑30份，姜半夏10‑20份，薏苡仁10‑20份，徐长卿20‑30份，鸡血藤20‑30份，朱砂根3‑5份。中药组方经济适用，从健脾胃，除湿气，理气，活血，解毒的方法治疗胰腺癌，适合各种年龄段的胰腺癌患者。可与多种化疗药物组合使用，缩小肿瘤病灶，延长肿瘤患者生存期；减少放化疗对身体的伤害和副作用，同时提高身体的免疫力和抗肿瘤能力。

Composition for Anti-Diabetes Using an Extract of Portulaca oleracea, etc.

The present invention discloses an anti-diabetic composition using a Portulaca oleracea extract, a Platycodon grandiflorus extract, and/or a Codonopsis lanceolate extract having α-glucosidase inhibitory activity. A composition of the present invention can be commercialized as food such as health functional food or medicine such as natural medicine.

A kind of antifatigue preparation of wine of enriching blood

本发明公开了一种抗疲劳补血葡萄酒的制备方法，包括：将红树莓、桑葚、杨梅和草莓加入水中，榨汁、过滤，加入护色剂搅匀得物料A；将葡萄破碎后榨汁，过滤得物料B；将桂花、金钗石斛、雪灵芝、红景天、党参、白术、鸡血藤、当归加入水中浸泡，捞出沥干水分，加入沸水中煎煮，过滤、浓缩、干燥得到物料C；将物料A、物料B、物料C和橙汁混匀得混合料，在混合料中加入蔗糖，调节体系的pH值为3‑4，加入偏重亚硫酸钾搅匀，灭菌后接种活化酿酒酵母，在25‑30℃下发酵6‑8.5天，过滤、澄清、调配。本发明提出的抗疲劳补血葡萄酒的制备方法，工艺简单，得到的葡萄酒酸甜可口，口感润滑，香味浓郁，同时具有抗疲劳、补血养血的保健功能。

Infusion composition that improves physical strength for improving muscle endurance and relieving fatigue

The present invention relates to a functional food composition for improving muscular endurance and relieving fatigue, and is characterized in that it contains Paeonia lactiflora, Astragalus propinquus, Angelica gigas, Levisticum officinale, Cervus nippon, and Platycodon grandiflorum. Therefore, by using six kinds of medicinal substance, it is beneficial in maintaining the quality of the muscle, and by increasing the glycogen content of the muscle, it is possible to improve muscular endurance and relieving fatigue.

Traditional Chinese medicine preparation for treating chronic cough and preparing method thereof

本发明提供了一种用于治疗慢性咳嗽的中药制剂，中药制剂的原料药包括炙麻黄、杏仁、生石膏、生甘草、竹茹、枳实、法半夏、生栀子、黄芩、桔梗、苏子、桑白皮、地骨皮、粳米、葶苈子、芦根、麦门冬、浙贝母、茯苓、瓜蒌、前胡、白前、炙百部、鱼腥草、陈皮、金银花、青黛、化橘红和蒲公英。本发明中药制剂在中医理论的指导下，根据大量的临床观察，对证型、临床表现及治疗预后等进行综合分析，组方用药，不仅具有止咳、平喘、化痰功效，并且通过动物实验验证，以及通过了中药安全性评价，证实本发明中药制剂具有很好的治疗慢性咳嗽的效果。

Liquid composition and the manufacturing method of electronic antismoking aid

PURPOSE: A liquid phase composition of an electronic anti-smoking aid is provided to maintain freshness in oral cavity and to ensure a visual effect of expressing smoke. CONSTITUTION: A method for manufacturing a liquid phase composition of an anti-smoking aid comprises: a step of preparing liquid phase concentrate from Berchemia berchmiaefolia (MAK.) KOIDZ. leaves or roots, ginseng or Platycodon grandiflorum (Jacq.) A. DC.; a step of adding spawn to the concentrate and fermenting and maturing the concentrate to prepare a fermented concentrate of pH 3-3.5; a step of adding 40-60 wt% of vegetable glycerin, 1-10 wt% of fermented concentrate, and remaining amount of propylene glycol. The liquid composition additionally contains 0.01-1 wt% of additives of coffee flavor, caffeine, menthol, lemon extract, mustard flavor, peppermint extract, spearmint extract, jasmine extract, or Glycyrrhiza extract.

Probiotic plant solid beverage for treating hyperuricemia and gout

本发明提供了一种用于治疗高尿酸及痛风的益生菌植物固体饮料。所述固体饮料是以冷冻干燥的益生菌菌粉与植物提取物，添加适宜辅料后混合制备得到的，所述固体饮料的组分包括植物提取物、辅料、益生菌，各组分的质量百分比为100％，其中所述植物提取物包括芹菜籽粉、槐米粉、桔梗粉。本发明在降低尿酸、缓解痛风方面作用效果显著。

A composition comprising an extract of combined crude drugs for treating and preventing abnormal metabolic diseases

본 발명은 혼합 생약 추출물을 이용한 대사성질환 예방 및 치료용 조성물 및 건강기능식품에 대한 것이다. 본 발명의 생약 추출물은 마우스 유래 지방세포인 3T3-L1 세포와 L6 근육세포에서 지방분화 억제 및 지방대사와 당대사를 개선시켜주는 효과가 있으므로 대사성질환 예방 및 치료용 약제 또는 건강기능식품에 유용하게 이용될 수 있다. The present invention relates to a composition for preventing and treating metabolic diseases using a mixed herbal extract and a health functional food. Since the herbal medicine extract of the present invention has an effect of inhibiting lipid differentiation and improving fat metabolism and glucose metabolism in 3T3-L1 cells and L6 muscle cells derived from mouse, it is useful for medicines for preventing or treating metabolic diseases or health functional foods Can be used.

A kind of nutrient health care wine and preparation method thereof

本发明涉及一种营养保健酒及其制备方法，属于保健酒技术领域。该保健酒由以下重量份的原料组成：虫草1份、鹿茸1份、党参1份、黄芪1份、麦冬1份、红花1份、红景天2份、玫瑰花2份、枸杞子3份、桑果干5份、蓝莓干5份、葡萄干5份、山枣5份、黄酒300份、樱桃2000份。本发明提供的营养保健酒中各个原料协同作用，能发挥更大的药效，在保留了各个原料常规保健作用的同时，更能美容养颜、强身健体、增强机体的免疫力，延缓衰老，提高人们的生活质量，该保健酒适宜女士四季均饮用。

Composition for prevention and treatment of muscular disorder or improvement of muscular functions comprising balloon-flower extract

본 발명은 길경 추출물을 함유하는 근육 질환 예방 및 치료용 또는 근 기능 개선용 조성물에 관한 것으로, 보다 상세하게는 길경 추출물을 포함하는 근육 질환 예방 및 치료용 약학 조성물, 근육 질환 예방용 또는 근 기능 개선용 식품 조성물 또는 근 기능 개선용 화장료에 관한 것이다. 본 발명의 길경 추출물은 근 단백질 합성 및 근육세포의 분화를 일으켜 근육 형성을 증가시킨다. 따라서 천연물이므로 부작용 없이 안전하게 사용될 수 있으며, 근육 질환 예방 및 치료 또는 근 기능 개선에 탁월한 효과를 보이는 약학적, 식품 또는 화장료 조성물의 유효한 성분으로 이용될 수 있다. The present invention relates to a composition for prevention and treatment of muscular diseases or a composition for improving muscular function, which contains Ganoderma extract, and more particularly to a composition for prevention and treatment of muscle diseases including Ganoderma lucidum extract, And a cosmetic composition for improving muscle function. The extract of Ganoderma lucidum of the present invention induces muscle protein synthesis and differentiation of muscle cells to increase muscle formation. Therefore, it can be used safely without side effects because it is a natural product, and it can be used as an effective ingredient of a pharmaceutical, food or cosmetic composition showing an excellent effect in prevention and treatment of muscular diseases or improvement of muscular function.

A kind of preparation method preventing and treating four high low deuterium-oxide beverages

本发明提供了一种预防和治疗四高的低氘水饮料的制备方法，方法为：1)制备香菇多糖；2)制备大豆蛋白肽水解液；3)将山楂、沙参、桔梗、桑叶、葛根、马齿苋、枸杞子、玉米须、黄芪和菊苣置于低氘水中，煮沸煎煮2‑3h，得中药提取液；4)将香菇多糖、大豆蛋白肽水解液和步骤3)制备的中药提取液混合，灭菌即得预防和治疗四高的低氘水饮料。与现有技术相比，本发明以低氘水为主要原料之一，控制香菇多糖，大豆蛋白肽的制备工艺，设计与山楂、沙参、桔梗、桑叶、葛根、马齿苋、枸杞子、玉米须、黄芪和菊苣的用量比，多种原料协同作用，能够达到降血脂、降血糖、降血压、降尿酸，治疗和预防四高的作用。